var title_f10_43_10928="Comminuted intertrochanteric hip fracture";
var content_f10_43_10928=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Comminuted intertrochanteric hip fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 279px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This&nbsp;anteroposterior radiograph&nbsp;shows a&nbsp;comminuted intertrochanteric fracture with displacement of the lesser trochanter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Koval KJ, MD and Zuckerman, JD, MD. Atlas of Orthopaedic Surgery: A Multimeidal Reference. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10928=[""].join("\n");
var outline_f10_43_10928=null;
var title_f10_43_10929="Bamboo spine in ankylosing spondylitis";
var content_f10_43_10929=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F74920&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F74920&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bamboo spine in ankylosing spondylitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 525px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    X-ray shows continuous fusion of the lumbar spine and lateral fusion of the sacroiliac joints.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Sheng Guang Li, PLA Hospital, China.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10929=[""].join("\n");
var outline_f10_43_10929=null;
var title_f10_43_10930="Bronchiectasis CF CT";
var content_f10_43_10930=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan of the lungs in a patient with cystic fibrosis, demonstrating bronchiectasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computerized tomography (CT)&nbsp;of the chest in a patient with cystic fibrosis demonstrates mild cylindrical bronchiectasis, with thickened bronchial walls involving the upper lobes and the superior segments of the lower lobes. Note the subsegmental atelectasis in the posterior segment of the right upper lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10930=[""].join("\n");
var outline_f10_43_10930=null;
var title_f10_43_10931="Lace up ankle brace";
var content_f10_43_10931=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F87055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F87055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 605px\">",
"   <div class=\"ttl\">",
"    Lace-up ankle brace",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 585px; height: 375px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During functional rehabilitation of an ankle sprain, a lace-up ankle support, such as the one pictured here, reduces instability and protects the ankle from further injury.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission. Copyright &copy; 2012 DJO, LLC. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10931=[""].join("\n");
var outline_f10_43_10931=null;
var title_f10_43_10932="Sexual maturity rating of breast development in girls";
var content_f10_43_10932=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sexual maturity rating (Tanner staging) of breast development in girls",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 329px; height: 570px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stages in breast development in girls.",
"    <br>",
"     Stage 1: Prepubertal, with no palpable breast tissue.",
"     <br>",
"      Stage 2: Development of a breast bud, with elevation of the papilla and enlargement of the areolar diameter.",
"      <br>",
"       Stage 3: Enlargement of the breast, without separation of areolar contour from the breast.",
"       <br>",
"        Stage 4: The areola and papilla project above the breast, forming a secondary mound.",
"        <br>",
"         Stage 5: Recession of the areola to match the contour of the breast; the papilla projects beyond the countour of the areola and breast.",
"         <div class=\"footnotes\">",
"         </div>",
"         <div class=\"reference\">",
"          Figure from: Roede MJ, van Wieringen JC. Growth diagrams 1980: Netherlands third nation-wide survey. Tijdschr Soc Gezondheids 1985; 63:1. Reproduced with permission from the author.",
"         </div>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10932=[""].join("\n");
var outline_f10_43_10932=null;
var title_f10_43_10933="Mutations in heme pocket";
var content_f10_43_10933=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F58767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F58767&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Mutations in heme pocket resulting in unstable hemoglobins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 388px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the heme pocket, showing the replacement site of several of the unstable hemoglobins. Valine E4 is at the corner of the pocket; its side chain does not make contact with the heme but does affect the placement of adjacent amino acid side chains.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Williamson, D, Brennan, SO, Muir, H, Carrell, RW, Hemoglobin 1983; 7:511. Copyright &copy; 1983 Marcel Dekker.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10933=[""].join("\n");
var outline_f10_43_10933=null;
var title_f10_43_10934="Diaphragmatic pacing";
var content_f10_43_10934=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diaphragmatic pacing",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10934/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10934/contributors\">",
"     Donald W Marion, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10934/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10934/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10934/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10934/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10934/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/43/10934/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphragmatic pacing was introduced over 40 years ago to treat patients with chronic apnea due to injury or disease of the central nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It provides a means to improve ventilation and eliminate the need for continuous positive pressure ventilatory support. The standard approach has been phrenic nerve pacing; however, direct pacing of the diaphragm muscle may be helpful in some patients.",
"   </p>",
"   <p>",
"    Diaphragmatic pacing can lead to a significant improvement in the quality of life of ventilator-dependent quadriplegic individuals. It can improve pulmonary function and reduce the incidence of pulmonary infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Most patients are able to speak while being paced, which contributes substantially to its clinical value. By restoring negative pressure ventilation, diaphragmatic pacing also restores or improves olfaction, which is typically lost during positive pressure ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diaphragmatic pacing will be reviewed here; The evaluation and management of bilateral diaphragmatic paralysis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14584?source=see_link\">",
"     \"Causes and diagnosis of bilateral diaphragmatic paralysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/27/44469?source=see_link\">",
"     \"Treatment of diaphragmatic paralysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphragmatic pacing should be considered for patients who have a central nervous system cause for apnea. The lesion in the central nervous system must be above the second or third cervical level, since pacing of the diaphragm by phrenic nerve stimulation is possible only if the nerve cell bodies (located in the anterior horns of C3-5) are viable.",
"   </p>",
"   <p>",
"    In contrast, trauma to the midcervical spine (C3, C4, C5 levels) usually does not allow pacing, because the cell bodies of the phrenic nerves are damaged. Diseases of the lower motor neurons or the anterior horn cells, such as polio or amyotrophic lateral sclerosis (ALS), have been considered contraindications to phrenic nerve pacing for the same reason. A small study of eight patients with ALS or other motor neuron disease found that phrenic nerve pacing did not increase ventilation-free survival compared with 354 patients using noninvasive positive pressure ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/5\">",
"     5",
"    </a>",
"    ]. However, a study of 38 patients with ALS found that pacing via electrodes implanted into the motor endplate zone of the diaphragm muscle (rather than the phrenic nerve) delayed the need for mechanical ventilatory support for up to two years, compared to historical controls from 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/6\">",
"     6",
"    </a>",
"    ]. Further study of diaphragmatic muscle pacing in patients with motor neuron disease is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The best candidates for phrenic nerve pacing include patients with [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/1,8-10\">",
"     1,8-10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete upper cervical spine injuries (eg, C1 and C2 levels) leading to apnea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/28/42439?source=see_link\">",
"       \"Respiratory complications of spinal cord injury\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some types of central sleep apnea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19140?source=see_link\">",
"       \"Central sleep apnea: Pathogenesis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Brainstem tumors or infarction.",
"     </li>",
"     <li>",
"      Basilar meningitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are considered candidates for diaphragmatic pacing if they fulfill the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Relatively normal cognitive function",
"     </li>",
"     <li>",
"      Complete respiratory paralysis without recovery for more than three months after the injury or onset of apnea",
"     </li>",
"     <li>",
"      Viable lower motor neurons for the phrenic nerves",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Contraindications to diaphragmatic pacing via phrenic nerve stimulation include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failure of the diaphragms to contract with percutaneous stimulation of the phrenic nerves",
"     </li>",
"     <li>",
"      Coma or obtundation",
"     </li>",
"     <li>",
"      Severe primary pulmonary disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Assessment of phrenic nerve function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The viability of the phrenic nerves is best determined by percutaneous electrical stimulation at the neck, using fluoroscopy to detect diaphragmatic movement [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Detection of diaphragmatic movement without the use of fluoroscopy may be misleading, as there have been cases in which diaphragmatic paralysis was misdiagnosed and fluoroscopic examination detected intact diaphragmatic function [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Timing of the testing of phrenic nerve function is somewhat controversial, but most agree that a minimum of three months should elapse following the acute event before testing is attempted. One study of three patients, for example, showed that phrenic nerves may be responsive when tested very early after injury, but subsequently become unresponsive within this initial three month period [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/14\">",
"     14",
"    </a>",
"    ]. The same investigators also demonstrated that initially unresponsive nerves may become responsive up to two years after the initial injury. Thus, patients who are initially excluded as candidates for diaphragmatic pacing should be periodically retested for at least two years after the injury to determine if there has been recovery of the phrenic nerves.",
"   </p>",
"   <p>",
"    Patient age is not considered an exclusion criterion, nor is the length of time from injury to pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/15\">",
"     15",
"    </a>",
"    ]. There are case reports of patients being successfully paced even after 32 months from the time of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Our own experience has suggested that patients should",
"    <strong>",
"     NOT",
"    </strong>",
"    be considered for diaphragmatic pacing if they have only weak diaphragmatic contraction in response to electrical stimulation in the neck, or if only one hemidiaphragm functions properly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HARDWARE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Phrenic nerve stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only phrenic nerve pacing system currently approved by the United States Food and Drug Administration (FDA) and widely marketed is the system manufactured by Avery Biomedical Devices [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/16\">",
"     16",
"    </a>",
"    ]. Their device and the costs for surgical implantation are approved by the US Center for Medicare &amp; Medicaid Services for Medicare reimbursement, and by most other insurance plans throughout the world.",
"   </p>",
"   <p>",
"    Unlike cardiac pacemakers, which have a completely internalized system, diaphragmatic pacers have both internal and external components. The system consists of:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An internal electrode, which is placed adjacent to the skeletonized phrenic nerve at surgery and is connected to a receiving unit in the shape of a small wafer placed under the skin.",
"     </li>",
"     <li>",
"      An external transmitting box connected to an antenna that is taped over the surface of the skin, just above the subcutaneous receiver.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The transmitting box is battery powered and contains screw adjustments for pulse duration, pulse train duration, respiratory rate, pulse frequency, and amplitude of the current. In most patients, the only adjustments made by the clinician are the amplitude and the respiratory rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Alternative approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alternative approaches are being developed for patients without intact phrenic nerve function or with only unilateral function. In these patients, direct stimulation of the diaphragmatic muscle may be an alternative to phrenic nerve stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Motor point mapping of the diaphragm is performed laparoscopically, using surgical tools and computer software to locate rapid motor points with a grid-mapping algorithm. Once the rapid motor points are identified, intramuscular electrodes are implanted into the motor points and connected to an external stimulator.",
"   </p>",
"   <p>",
"    In quadriplegic patients with only unilateral phrenic nerve function, phrenic nerve stimulation has been combined with intercostal muscle stimulation via a multipolar disc electrode positioned on the ventral surface of the upper thoracic spinal cord [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/19\">",
"     19",
"    </a>",
"    ]. The combination of phrenic and intercostal nerve stimulation increased maximum inspired volume, even though only one hemidiaphragm was used for ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SURGICAL IMPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two common locations where the electrode is placed adjacent to the phrenic nerve: in the neck (cervical approach) or in the chest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Placement in the neck",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the cervical approach, the phrenic nerve is identified between the anterior and middle scalene muscles in the neck. A transverse skin incision is made in the midportion of the neck, just lateral to the sternocleidomastoid muscle, and the surgeon dissects out the borders of the scalene muscles. The two scalene muscles are then divided, and the phrenic nerve is identified lying in a layer of fascia just anterior to the anterior surface of the middle scalene muscle. Identification of the nerve is often facilitated by the use of a hand-held nerve stimulator combined with intraoperative fluoroscopy to allow observation of diaphragmatic contraction in response to phrenic nerve stimulation.",
"   </p>",
"   <p>",
"    Once identified, the phrenic nerve is carefully dissected free of its investing fascia, and the U-shaped electrode is placed under it and secured with sutures. Care must be taken to avoid damaging the nerve. The connecting wire from the electrode is then tunneled subcutaneously to a subcutaneous pocket that is created just below the ipsilateral clavicle. The connections are made and sealed, and wounds are closed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Placement in the chest",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative approach for diaphragmatic pacer implantation is through the chest, using either a standard thoracotomy incision between the third and fourth ribs, or via a thoracoscopic approach [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/20\">",
"     20",
"    </a>",
"    ]. The phrenic nerve on the right side is located along the mediastinum just posterior or lateral to the esophagus, and on the left side lying lateral to the pericardium. The nerve is freed of its fibrous investments, and the electrode is placed under it and secured with sutures. The electrode is connected to the receiver, which is placed in a subcutaneous pocket.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Choosing between the options",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advantage of the cervical approach to electrode placement is that it avoids the morbidity of bilateral thoracotomies, which may not be well tolerated in patients with marginal pulmonary function or a history of severe pulmonary contusions. The disadvantage of the cervical procedure is that, in a small proportion of patients, the amplitude of current necessary to stimulate the phrenic nerve results in transmission of current through the soft tissues. This stimulates the functioning portions of the brachial plexus, leading to rhythmic jerking motions of the upper extremities.",
"   </p>",
"   <p>",
"    An advantage of the chest approach is that inadvertent stimulation of portions of the brachial plexus may be avoided. In addition, there is some neuroanatomic evidence that a small branch of the phrenic nerve joins the main nerve trunk only after it enters the chest cavity. As a result, a larger portion of the phrenic nerve may be stimulated by the chest approach. Thoracoscopic lead placement is an alternative for those unable to tolerate thoracotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TESTING THE PACEMAKER",
"    </span>",
"    &nbsp;&mdash;&nbsp;During surgery, after the electrode has been secured and connected to the receiver, it is tested to ensure that there is excellent contact with the nerve and that stimulation through the receiver results in good diaphragmatic contraction. An initial stimulation strength of three to six milliamps may be required, particularly if the patient has had no diaphragmatic function for six months or more. The amplitude that provides maximal diaphragmatic contraction should be used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CONDITIONING OF THE DIAPHRAGM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have not had diaphragm function for six months, particularly those who have had paralyzed diaphragms for two or more years, require a period of diaphragm conditioning that may last up to nine months before achieving optimal diaphragm functioning through pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/8,21\">",
"     8,21",
"    </a>",
"    ]. The routine for diaphragm conditioning varies considerably from patient to patient.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Typically, conditioning requires a gradually increasing duration of pacing time per hour during the day, followed by 10 to 12 hours of rest, when the patient is placed on positive pressure ventilation.",
"     </li>",
"     <li>",
"      Pulse oximetry and arterial blood gases are monitored frequently.",
"     </li>",
"     <li>",
"      Hypercapnia can usually be avoided by adjusting the ventilatory rate. In our experience, this has been one of the more common problems encountered during the conditioning interval.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The manufacturer of diaphragmatic pacing hardware is a source of advice and support during the conditioning process. The paucity of literature on diaphragmatic pacing and the limited application of the technique make the manufacturer a \"clearing house\" for information regarding practical aspects. Hopefully, as research on the subject grows, the peer-review literature will assume this function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of diaphragmatic pacing include those related to the surgery and those related to the process of pacing. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infection following surgery",
"     </li>",
"     <li>",
"      Pulmonary complications following a thoracic surgical approach",
"     </li>",
"     <li>",
"      Dislodgement of the pacer electrode",
"     </li>",
"     <li>",
"      Transmission of pacer impulses to the brachial plexus, with rhythmic jerking of the upper extremity (seen with neck placement of the electrode)",
"     </li>",
"     <li>",
"      Malfunction of hardware",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, diaphragmatic pacing provides patients with a sense of independence that cannot be achieved with a positive pressure ventilator, no matter how compact or portable. Patients also appreciate the opportunity for unlimited verbal communication, which is lost to a variable extent with positive pressure ventilatory support.",
"   </p>",
"   <p>",
"    Assessment of outcomes of diaphragmatic pacing comes from case reports and retrospective series [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/3,6,20,22-26\">",
"     3,6,20,22-26",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective analysis of 12 quadriplegic patients, who underwent phrenic nerve pacemaker placement at a single center between 1981 and 1987, suggests that chronic pacing is not associated with progressive diaphragmatic dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/3,22\">",
"       3,22",
"      </a>",
"      ]. Six patients from this cohort continued to be paced full time, for a median of over 14 years. Pacing was well tolerated, and reasons for discontinuation included intercurrent medical illness and lack of social support [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A single center report reviewed the experience with 22 young people (mean age of 12 years), all with ventilatory dysfunction secondary to high spinal cord injury, brainstem injury, or central alveolar hypoventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/23\">",
"       23",
"      </a>",
"      ]. Successful pacing was reported for 11 years in one patient, 10 years in four patients, and five years or less for 17 patients. Only two patients failed all efforts at diaphragmatic pacing.",
"     </li>",
"     <li>",
"      A single center study of 20 patients, 19 of whom had posttraumatic tetraplegia, evaluated the results of video-assisted thoracoscopic phrenic electrode placement between 1997 and 2007 [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/20\">",
"       20",
"      </a>",
"      ]. There were no operative complications, and 18 of the patients were successfully weaned from positive-pressure ventilation. Median diaphragm reconditioning time was six weeks.",
"     </li>",
"     <li>",
"      A retrospective report of diaphragmatic pacing for patients with congenital central alveolar hypoventilation syndrome found that all six patients treated over a 20 year span (ages 4 to 23) were ventilator-free during the day and had active, productive lives in school or at work [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The outcomes for direct diaphragm stimulation (laparoscopic motor point electrode insertion) were reported for 50 adults with high spinal cord injuries and 38 adults with ALS [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10934/abstract/6\">",
"       6",
"      </a>",
"      ]. Time from spinal cord injury to implantation was from 3 months to 27 years. The procedure was successful (able to be off the ventilator for at least four hours each day) for 96 percent of the spinal cord injury patients. For those with ALS, diaphragm pacing was found to delay the need for mechanical ventilation for up to two years.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H473505\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diaphragmatic pacing is used for patients with bilateral diaphragmatic paralysis who have a central nervous system cause for apnea. The lesion in the central nervous system must be above the second or third cervical level, since pacing of the diaphragm by phrenic nerve stimulation is possible only if the nerve cell bodies (located in the anterior horns of C3-5) are viable. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most candidates for diaphragmatic pacing have complete respiratory paralysis without recovery for more than three months after high cervical injury or the onset of apnea. Phrenic nerve pacing requires functioning of the lower motor neuron portions of the phrenic nerves. Direct diaphragmatic pacing is possible in patients with diaphragmatic paralysis without intact phrenic nerve function or for diseases such as amyotrophic lateral sclerosis (ALS) that damage the lower motor neurons from which the phrenic nerves originate. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Hardware'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The viability of the phrenic nerves is best determined by percutaneous electrical stimulation at the neck, using fluoroscopy to detect diaphragmatic movement. Occasionally, phrenic nerves will be unresponsive after an injury, but become responsive months to years later. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The phrenic nerves can be paced from the neck or the chest. Placement of the electrodes in the neck is associated with less surgical morbidity, but may be associated with unwanted stimulation of the brachial plexus. Placement of electrodes on the intrathoracic phrenic nerves can be accomplished thoracoscopically, which avoids much of the morbidity associated with open thoracotomy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Surgical implantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During surgery, after the electrode has been secured and connected to the receiver, the circuit is tested to ensure that stimulation through the receiver results in good diaphragmatic contraction. An initial stimulation strength of three to six milliamps may be required, particularly if the patient has had no diaphragmatic function for six months or more. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Testing the pacemaker'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A period of diaphragm conditioning is needed before achieving optimal diaphragm functioning through pacing. Typically, conditioning requires a program of gradually increasing the duration of pacing time during the day, followed by 10 to 12 hours of rest on the ventilator. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Conditioning of the diaphragm'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of diaphragmatic pacing include infection, hardware malfunction, electrode dislodgement, adverse effects of the surgical procedure, and inadvertent transmission of pacer impulses to the brachial plexus. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diaphragmatic pacing is successful in the majority of patients who meet initial criteria and provides patients with a sense of independence that cannot be achieved with a positive pressure ventilator. An additional benefit is the ability to talk, which is difficult during positive pressure ventilation. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/1\">",
"      Glenn WW, Holcomb WG, McLaughlin AJ, et al. Total ventilatory support in a quadriplegic patient with radiofrequency electrophrenic respiration. N Engl J Med 1972; 286:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/2\">",
"      Judson JP, Glenn WW. Radio-frequency electrophrenic respiration. Long-term application to a patient with primary hypoventilation. JAMA 1968; 203:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/3\">",
"      Elefteriades JA, Hogan JF, Handler A, Loke JS. Long-term follow-up of bilateral pacing of the diaphragm in quadriplegia. N Engl J Med 1992; 326:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/4\">",
"      Adler D, Gonzalez-Bermejo J, Duguet A, et al. Diaphragm pacing restores olfaction in tetraplegia. Eur Respir J 2009; 34:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/5\">",
"      Mahajan KR, Bach JR, Saporito L, Perez N. Diaphragm pacing and noninvasive respiratory management of amyotrophic lateral sclerosis/motor neuron disease. Muscle Nerve 2012; 46:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/6\">",
"      Onders RP, Elmo M, Khansarinia S, et al. Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc 2009; 23:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/7\">",
"      McDermott CJ, Maguire C, Cooper CL, et al. Protocol for diaphragm pacing in patients with respiratory muscle weakness due to motor neurone disease (DiPALS): a randomised controlled trial. BMC Neurol 2012; 12:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/8\">",
"      Glenn WW, Hogan JF, Loke JS, et al. Ventilatory support by pacing of the conditioned diaphragm in quadriplegia. N Engl J Med 1984; 310:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/9\">",
"      Yasuma F, Sakamoto M, Okada T, Abe K. Eight-year follow-up study of a patient with central alveolar hypoventilation treated with diaphragm pacing. Respiration 1998; 65:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/10\">",
"      Elefteriades JA, Quin JA. Diaphragm pacing. Ann Thorac Surg 2002; 73:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/11\">",
"      Shaw RK, Glenn WW, Hogan JF, Phelps ML. Electrophysiological evaluation of phrenic nerve function in candidates for diaphragm pacing. J Neurosurg 1980; 53:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/12\">",
"      Alshekhlee A, Onders RP, Syed TU, et al. Phrenic nerve conduction studies in spinal cord injury: applications for diaphragmatic pacing. Muscle Nerve 2008; 38:1546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/13\">",
"      McCauley RG, Labib KB. Diaphragmatic paralysis evaluated by phrenic nerve stimulation during fluoroscopy or real-time ultrasound. Radiology 1984; 153:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/14\">",
"      Lieberman JS, Corkill G, Nayak NN, et al. Serial phrenic nerve conduction studies in candidates for diaphragm pacing. Arch Phys Med Rehabil 1980; 61:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/15\">",
"      Shaul DB, Danielson PD, McComb JG, Keens TG. Thoracoscopic placement of phrenic nerve electrodes for diaphragmatic pacing in children. J Pediatr Surg 2002; 37:974.",
"     </a>",
"    </li>",
"    <li>",
"     Breathing pacemakers. file://www.averylabs.com (Accessed on March 20, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/17\">",
"      Onders RP, Ponsky TA, Elmo M, et al. First reported experience with intramuscular diaphragm pacing in replacing positive pressure mechanical ventilators in children. J Pediatr Surg 2011; 46:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/18\">",
"      Onders RP, Khansarinia S, Weiser T, et al. Multicenter analysis of diaphragm pacing in tetraplegics with cardiac pacemakers: positive implications for ventilator weaning in intensive care units. Surgery 2010; 148:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/19\">",
"      DiMarco AF, Takaoka Y, Kowalski KE. Combined intercostal and diaphragm pacing to provide artificial ventilation in patients with tetraplegia. Arch Phys Med Rehabil 2005; 86:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/20\">",
"      Le Pimpec-Barthes F, Gonzalez-Bermejo J, Hubsch JP, et al. Intrathoracic phrenic pacing: a 10-year experience in France. J Thorac Cardiovasc Surg 2011; 142:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/21\">",
"      Chervin RD, Guilleminault C. Diaphragm pacing for respiratory insufficiency. J Clin Neurophysiol 1997; 14:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/22\">",
"      Elefteriades JA, Quin JA, Hogan JF, et al. Long-term follow-up of pacing of the conditioned diaphragm in quadriplegia. Pacing Clin Electrophysiol 2002; 25:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/23\">",
"      Garrido-Garcia H, Mazaira Alvarez J, Mart&iacute;n Escribano P, et al. Treatment of chronic ventilatory failure using a diaphragmatic pacemaker. Spinal Cord 1998; 36:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/24\">",
"      Ali A, Flageole H. Diaphragmatic pacing for the treatment of congenital central alveolar hypoventilation syndrome. J Pediatr Surg 2008; 43:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/25\">",
"      Lassman AB, Mayer SA. Paroxysmal apnea and vasomotor instability following medullary infarction. Arch Neurol 2005; 62:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10934/abstract/26\">",
"      Morgan JA, Morales DL, John R, et al. Endoscopic, robotically assisted implantation of phrenic pacemakers. J Thorac Cardiovasc Surg 2003; 126:582.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5117 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-961E418322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10934=[""].join("\n");
var outline_f10_43_10934=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H473505\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Assessment of phrenic nerve function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HARDWARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Phrenic nerve stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Alternative approaches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SURGICAL IMPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Placement in the neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Placement in the chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Choosing between the options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TESTING THE PACEMAKER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CONDITIONING OF THE DIAPHRAGM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H473505\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14584?source=related_link\">",
"      Causes and diagnosis of bilateral diaphragmatic paralysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19140?source=related_link\">",
"      Central sleep apnea: Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/28/42439?source=related_link\">",
"      Respiratory complications of spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/27/44469?source=related_link\">",
"      Treatment of diaphragmatic paralysis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_43_10935="Renal hypoplasia";
var content_f10_43_10935=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Renal hypoplasia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10935/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10935/contributors\">",
"     Patrick Niaudet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10935/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10935/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10935/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10935/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/43/10935/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal renal development is dependent upon the interaction between the ureteric bud and metanephric mesenchyme, which induces organogenesis resulting in the formation of the 600,000 to two million nephrons and the collecting system of each kidney.",
"   </p>",
"   <p>",
"    The following renal malformations arise when this process is disrupted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal aplasia (agenesis) &mdash; Congenital absence of kidney(s).",
"     </li>",
"     <li>",
"      Renal hypoplasia &mdash; Congenitally small kidneys with a reduced number of nephrons but normal architecture. Pure renal hypoplasia is a rare condition.",
"     </li>",
"     <li>",
"      Renal dysplasia &mdash; The presence of malformed renal tissue elements, including primitive tubules, interstitial fibrosis,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the presence of cartilage in the renal parenchyma.",
"     </li>",
"     <li>",
"      Renal hypodysplasia &mdash; Congenitally small kidney with dysplastic features. Renal hypoplasia is more commonly associated with dysplasia than without.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These renal conditions account for 20 percent of end-stage renal disease in children. These malformations, along with lower urinary tract abnormalities, constitute a spectrum of disorders referred to as congenital abnormalities of the kidney and urinary tract (CAKUT). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=see_link\">",
"     \"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Renal hypoplasia will be reviewed here. CAKUT, including renal dysplasia and agenesis, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)\", section on 'Renal dysplasia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=see_link&amp;anchor=H9#H9\">",
"     \"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)\", section on 'Renal agenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16296?source=see_link\">",
"     \"Prenatal diagnosis of renal agenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three forms of renal hypoplasia have been reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oligomeganephronia &mdash; In which the kidneys are small with a reduction in the calyces and number of nephrons",
"     </li>",
"     <li>",
"      Simple hypoplasia &mdash; In which the kidneys are small but appear architecturally normal with a normal density of nephrons",
"     </li>",
"     <li>",
"      Unipapillary hypoplastic kidney &mdash; In which there is a single papilla",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common renal hypoplasia variant is oligomeganephronia. Unipapillary form is rare, and it remains unclear the incidence of simple hypoplasia. The following discussion primarily is based upon the oligomeganephronic form of renal hypoplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal hypoplasia is usually clinically diagnosed based on [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal ultrasonography findings of a reduction of renal size by greater than 2 standard deviations for the mean size by age, typically evaluated by renal ultrasonography [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/1\">",
"       1",
"      </a>",
"      ]. The kidneys remain symmetrical and reniform in shape [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Exclusion of renal scarring by 99mTc&ndash;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/22/8548?source=see_link\">",
"       dimercaptosuccinic acid",
"      </a>",
"      (DMSA) radionuclide scan can also be performed to exclude the presence of renal scarring but is not routinely performed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis can be confirmed by histologic examination, which is usually not performed. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H6\">",
"     'Pathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Renal hypoplasia may be either bilateral or unilateral. In cases of unilateral involvement, compensatory hypertrophy of the contralateral kidney also is generally present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16296?source=see_link\">",
"     \"Prenatal diagnosis of renal agenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Renal hypoplasia may be a component of a genetic syndrome (eg, renal-coloboma and branchio-oto-renal syndromes) or present as an isolated finding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal atrophy has many of the same clinical features as renal hypoplasia. It may be important to differentiate between the two entities because renal hypoplasia may be caused by a genetic disorder, which may have implications for the patient's family. The two entities may be separated by the clinical history, association with urinary tract malformations, and a histologic examination of the whole kidney (if available).",
"   </p>",
"   <p>",
"    Renal hypoplasia is a congenital disorder that is generally not associated with an urinary tract malformation but may be a component of a genetic syndrome. Histologically, in patients with the oligomeganephronic form of renal hypoplasia, there is a reduced number of nephrons with hypertrophy of the glomeruli and tubules. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Pathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In contrast, renal atrophy is an acquired condition that is often associated with urinary tract malformations (eg, vesicoureteral reflux). The histologic examination demonstrates areas of atrophic tubules with sclerotic glomeruli and, occasionally, areas of parenchyma with hypertrophic glomeruli. Areas of sclerotic glomeruli and renal tubular atrophy (ie, renal scar) may correspond to areas of decreased tracer uptake when DMSA radionuclide scan is performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOLOGY AND PATHOGENESIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oligomeganephronic form of renal hypoplasia is characterized by the following histopathologic features [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smaller kidneys &mdash; Kidney weight that is less than 50 percent of age matched normal controls.",
"     </li>",
"     <li>",
"      Low number of nephrons &mdash; The kidneys of patients with renal hypoplasia have only 20 to 25 percent of the normal total number of nephrons.",
"     </li>",
"     <li>",
"      Hypertrophic glomeruli &mdash; The diameter of glomeruli is twice the normal glomerular size (250 to 325 microns versus 100 to 150 microns).",
"     </li>",
"     <li>",
"      Hypertrophic tubules &mdash; Affected tubules are both longer (four times the normal length) and larger (15 times the normal volume for age) than normal [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other &mdash; Thickening of Bowman's capsule and variable abnormalities of the glomerular basal membrane are seen [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/5\">",
"       5",
"      </a>",
"      ]. Electron microscopy also reveals irregular thickening and fusion of epithelial cell foot processes [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Over time, most patients with renal hypoplasia develop end-stage-renal disease with histologic changes that include interstitial fibrosis and tubular atrophy (",
"    <a class=\"graphic graphic_picture graphicRef51309 \" href=\"UTD.htm?18/28/18889\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal hypoplasia, particularly the oligomeganephronic form, is believed to result from developmental arrest of the metanephric renal blastema between the 14th and the 20th week of fetal life. This causes a decrease in the number of developing nephrons leading to hypertrophy of the remaining nephrons. This condition of small symmetrical kidneys with a reduction of nephrons, which are hypertrophic, is often referred to as oligomeganephronia.",
"   </p>",
"   <p>",
"    Support for a major defect in the development of the renal blastema as the cause of renal hypoplasia was provided by histological examination of two cases of oligomeganephronia with contralateral renal agenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/7\">",
"     7",
"    </a>",
"    ]. In both cases (an 18-week fetus and a preterm infant), the development of the metanephric blastema was deficient, resulting in a reduced blastema compared to normal controls [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/7\">",
"     7",
"    </a>",
"    ]. Additional findings included a reduction in the number of glomeruli per gram of parenchyma, and severe hypertrophy combined with a decreased number of nephron generations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although it remains unknown what causes renal hypoplasia, two possible causes include in utero vascular abnormalities and genetic developmental disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Vascular abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Support for in utero vascular abnormalities includes several cases of renal hypoplasia affecting only one of two homozygous twins [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In some cases, a placenta vascular shunt at a critical developmental period appears to have impaired kidney development. Other types of vascular accidents also might be involved, including disseminated intravascular coagulation or embolization of necrotic pieces, following the death in utero of the twin fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, intrauterine growth restriction may be associated with a reduction in nephron number [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Genetic mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal hypoplasia has been observed in association with several genetic disorders, including the renal-coloboma syndrome, branchio-oto-renal syndrome, and renal dysgenesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Renal-coloboma syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 20 heterozygous mutations in the PAX2 gene have been described in patients with the renal-coloboma syndrome (MIM 120330), also known as the papillorenal syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/13\">",
"     13",
"    </a>",
"    ]. Renal-coloboma syndrome is an autosomal dominant disease generally characterized by renal hypoplasia, vesicoureteral reflux, and optic nerve coloboma [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies of the 1Neu mice have shown a critical role of PAX2 during kidney development by preventing apoptosis during the branching of the ureteric bud [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Identified PAX2 mutations have mostly been located in the second and third exons of the PAX2 gene, which is located on chromosome 10q24-25 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other renal malformations may be observed, such as renal dysplasia, multicystic dysplastic kidney, or ureteropelvic junction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/18\">",
"     18",
"    </a>",
"    ]. Ophthalmologic examination shows an optic disc split and vascular anomalies associated with variable visual impairment. Other features include sensorineural hearing loss, Arnold Chiari malformation, seizures and joint laxity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=see_link&amp;anchor=H10#H10\">",
"     \"Congenital anomalies and acquired abnormalities of the optic nerve\", section on 'Optic disc coloboma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Branchio-oto-renal syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Branchio-oto-renal (BOR) syndrome (MIM 113650) is an autosomal dominant disorder that combines branchial defects, ear pits, hearing loss, and renal anomalies, including renal hypoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. More than 50 mutations in the EYA1 gene on chromosome 8q13.3 have been identified in patients with BOR syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. EYA1 gene encodes for a transcription cofactor that is expressed in the metanephric mesenchyme during kidney development [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/24\">",
"     24",
"    </a>",
"    ]. The EYA1 gene interacts with members of the SIX family, which encodes transcription factors that control expression of PAX2 and GDNF in the metanephric mesenchyme. Mutations in SIX1 (chromosome 14q23.1) and SIX5 genes have also been reported in families with the BOR syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/25-27\">",
"     25-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this syndrome, penetrance is incomplete, and patients may have only one or two features of the syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/28\">",
"     28",
"    </a>",
"    ]. Renal anomalies are not observed in all patients and may differ in individuals of the same family. Renal findings include renal agenesis or hypoplasia (which may be unilateral or bilateral), vesicoureteral reflux, or ureteral duplication. If renal hypoplasia is present, it may vary in severity. Ear abnormalities include periauricular pits, anomalies of the middle and external ear, and hypoplasia of the cochlea, resulting in hearing loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12055?source=see_link&amp;anchor=H9#H9\">",
"     \"Congenital anomalies of the ear\", section on 'Preauricular pits'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Isolated renal hypoplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reported cases of isolated renal hypoplasia have been associated with PAX2 mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. However, upon closer examination, many of these patients also had ocular findings, suggesting that the disorder was not isolated only to the kidney. As a result, one must be cautious in accepting reported cases of completely isolated renal hypoplasia due to a PAX2 mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other cases of isolated renal hypodysplasia have been associated with mutation of genes that encode transcription factors including TCF2 (HNF-1beta), PAX2, EYA1 and SALLI [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported symptoms of renal hypoplasia are primarily based upon observations in patients with oligomeganephronia. These findings depend, in part, upon the age at presentation. Patients with more severe involvement will present at a younger age because of a greater degree of renal impairment. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Course of renal function'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Neonate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The birth weight of patients with renal hypoplasia is often below the normal mean because of the association of intrauterine growth retardation and renal hypoplasia.",
"   </p>",
"   <p>",
"    In the neonatal period, patients may present with one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pneumothorax",
"     </li>",
"     <li>",
"      Feeding difficulties",
"     </li>",
"     <li>",
"      Metabolic acidosis",
"     </li>",
"     <li>",
"      Urinary sodium losses",
"     </li>",
"     <li>",
"      High plasma creatinine and urea",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     First year of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the first year of life, persistent anorexia with vomiting is the usual presentation of renal hypoplasia. Failure to thrive is also seen in more than 50 percent of cases, and patients often exhibit growth retardation that is greater than expected based on the level of their renal function impairment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     After one year of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;After one year of age, the most common presenting abnormality is proteinuria discovered incidentally on routine urine examination. In other patients, the disease may be discovered because of impaired growth, or polyuria and polydipsia. Renal failure can also present as anemia or osteodystrophy secondary to hyperparathyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ultrasonographic or radiographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal ultrasonography in children with renal hypoplasia reveals reduced kidney size (20 to 75 percent of normal) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Affected kidneys also are hyperechogenic on ultrasonography. Although serial sonography shows an increase in absolute kidney size over time, the increase rate is smaller than that observed in normal children.",
"   </p>",
"   <p>",
"    There appears to be no relationship between initial kidney size and the evolution of renal function with time. Visualization of the urinary tract does not reveal any malformations, such as renal cavity distension or vesicoureteral reflux.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     COURSE OF RENAL FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the vast majority of patients with renal hypoplasia have a similar degree of nephron reduction, changes in renal function vary from patient to patient. The reasons for these differences remain unclear. Several hypotheses have been proposed, including mutations in the angiotensin converting enzyme gene (as has already been shown in other nephropathies) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Over time, most patients with renal hypoplasia develop end-stage-renal disease (ESRD). Progressive renal failure is due, in part, to focal segmental glomerulosclerosis, which develops in the reduced number of nephrons because of hyperfiltration and increased glomerular size (which also raises the stress on the glomerular capillary wall) in the hypertrophied glomeruli. This process is similar to that seen with other renal conditions with nephron loss, and may be slowed by antihypertensive therapy, particularly with an angiotensin converting enzyme (ACE) inhibitor. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Patients with renal failure'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The course of renal function starting from infancy through childhood was observed in a large case series of patients with renal hypoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/37\">",
"     37",
"    </a>",
"    ]. Renal function (ie, glomerular function rate [GFR]) rapidly increased during the first months of life. After this early period, renal function continued to increase but at a slower pace than age-matched normative data. In patients with the most severe degree of renal impairment, maximal GFR is reached within the first year of life, whereas, in most other patients, maximal GFR is attained between three and six years of age.",
"   </p>",
"   <p>",
"    The maximum level of GFR varied, ranging between 6 and 100",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73m2 as calculated by the Schwartz formula based upon the patient's serum creatinine and height. The older the age at which the maximum GFR is reached, the higher the maximal GFR achieved, and the older the age at which the patient develops ESRD. There was good correlation between the GFR at one year and the highest GFR eventually observed; there was, however, no correlation between maximal GFR and kidney size. Therefore, it is necessary to wait at least until one year of age in order to reliably predict if and when ESRD will occur.",
"   </p>",
"   <p>",
"    Once the maximum GFR was reached, renal function remained at this level for a variable period of time. The length of this period depended, in part, on the absolute level of renal function and number of nephrons. As an example, patients with maximum filtration rates of 40",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    or more &nbsp;experienced stable renal function for at least four years.",
"   </p>",
"   <p>",
"    Onset of proteinuria is an indication of the development of focal segmental glomerulosclerosis. Proteinuria generally precedes the deterioration of renal function by several years. Initially, proteinuria is lower than 0.5",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    but increases with progressive decrease of renal function. The degree of proteinuria is higher when the functional loss is more than 5",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per year. Once deterioration of renal function begins, it progresses at a constant rate. Most patients develop ESRD at middle or late childhood at the end of the first decade of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Patients with renal failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic examination of the kidneys in patients with renal hypoplasia and ESRD reveals focal segmental glomerular sclerosis and interstitial fibrosis, resulting in nephron obsolescence. Similar lesions are observed in rats that have undergone five-sixths nephrectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    End-stage kidneys removed in patients with oligomeganephronia at the time of transplantation are very small in size with a reduced number of papillae. In this setting, histological examination allows the clinician to confirm or to make the diagnosis of renal hypoplasia, and reveals unusual numbers, sizes, and characteristics of nephrons [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The number of glomerular generations is extremely reduced, and varies from 2 to 6 depending in part upon the area of the kidney examined. By comparison, the normal number is at least 10.",
"     </li>",
"     <li>",
"      There is a relatively high proportion of permeable glomeruli. The diameter of these glomeruli is increased to more than 300 microns and often reaches 400 microns (in contrast, normal glomeruli have a diameter of 100 to 150 microns). Adjacent proximal tubules are also similarly hypertrophied.",
"     </li>",
"     <li>",
"      Segmental sclerosis and hyalinosis of glomeruli is consistently observed [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10935/abstract/37,39\">",
"       37,39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no specific treatment for renal hypoplasia other than supportive management, which includes maintaining fluid and electrolyte balance, and promoting growth. The latter may entail the use of recombinant growth hormone therapy. As noted above, ACE inhibitors may be given in an attempt to slow the progression to end-stage renal failure particularly in those patients who develop proteinuria. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Course of renal function'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27881?source=see_link\">",
"     \"Growth hormone treatment in children with chronic kidney disease and postrenal transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13206?source=see_link\">",
"     \"Antihypertensive therapy and progression of chronic kidney disease: Experimental studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with renal hypoplasia uniformly progress to ESRD. Renal transplantation is the preferred therapy in patients with ESRD because reported outcome is excellent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal hypoplasia is a renal developmental malformation. There are three forms of renal hypoplasia. Most patients with renal hypoplasia have oligomeganephronia, which is characterized by a reduction in number of nephrons (20 to 25 percent of normal), hypertrophic glomeruli (two or three times normal size), and tubules (four times normal length), and with variable thickening of Bowman's capsule and the glomerular basement membrane. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal hypoplasia is a rare condition and is usually diagnosed clinically based upon renal imaging demonstrating small symmetrical kidneys that are below 2 standard deviations in size and excluding renal scarring. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal hypoplasia is thought to be caused by disruption of normal renal development either due to a vascular or genetic abnormality that results in the developmental arrest of the metanephric renal blastema between the 14th and the 20th week of fetal life. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal hypoplasia may occur as an isolated finding or as a component of a genetic syndrome, such as renal-coloboma and branchio-oto-renal syndromes, and renal tubular dysgenesis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Genetic mutations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical presentation of renal hypoplasia varies depending upon the age at presentation. In general, patients with more severe involvement will present at a younger age because of a greater degree of renal impairment. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the vast majority of patients with renal hypoplasia have a similar degree of nephron reduction, changes in renal function vary from patient to patient. Over time, most patients with renal hypoplasia progress to end-stage-renal disease because of the development of focal segmental glomerulosclerosis and interstitial fibrosis. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Course of renal function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no specific treatment for renal hypoplasia. Renal transplantation is the preferred therapy in patients with ESRD because reported outcome is excellent. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/1\">",
"      Sanna-Cherchi S, Caridi G, Weng PL, et al. Genetic approaches to human renal agenesis/hypoplasia and dysplasia. Pediatr Nephrol 2007; 22:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/2\">",
"      Griffel B, Pewzner S, Berandt M. Unilateral \"oligom&eacute;gan&eacute;phronie\" with agenesis of the contralateral kidney. Studied by microdissection. Virchows Arch A Pathol Pathol Anat 1972; 357:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/3\">",
"      Nomura S, Osawa G. Focal glomerular sclerotic lesions in a patient with unilateral oligomeganephronia and agenesis of the contralateral kidney: a case report. Clin Nephrol 1990; 33:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/4\">",
"      ROYER P, HABIB R, MATHIEU H, COURTECUISSE V. [Congenital bilateral renal hyperplasia with reduction of the number and hypertrophy of the nephrons in children]. Ann Pediatr (Paris) 1962; 9:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/5\">",
"      Fetterman, GH, Habib, R. Congenital bilateral oligonephronic renal hypoplasia with hypertrophy of nephrons [oligom&eacute;gan&eacute;phronie]. Studies by microdissection. Am J Clin Pathol 1969; 52:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/6\">",
"      Morita T, Wenzl J, McCoy J, et al. Bilateral renal hypoplasia with oligomeganephronia: quantitative and electron microsopic study. Am J Clin Pathol 1973; 59:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/7\">",
"      Foster SV, Hawkins EP. Deficient metanephric blastema--a cause of oligomeganephronia? Pediatr Pathol 1994; 14:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/8\">",
"      Ng WL, Cheung MF, Chan CW, Yu CL. Oligomeganephronic renal hypoplasia. Pathology 1980; 12:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/9\">",
"      Mansour A, Reye RD, Roy LP. Oligomeganephronia with covered anus in twins. Aust Paediatr J 1977; 13:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/10\">",
"      Weir MR, Salinas JA, Rawlings PC. Intrauterine twin demise and oligomeganephronia. Nephron 1985; 40:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/11\">",
"      Leroy, B, Josset, P, Morgan, G, et al. Intrauterine growth retardation (IUGR) and nephron deficit: Preliminary study in man. Pediatr Nephrol 1992; 6:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/12\">",
"      Hinchliffe SA, Lynch MR, Sargent PH, et al. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992; 99:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/13\">",
"      Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995; 9:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/14\">",
"      Weaver RG, Cashwell LF, Lorentz W, et al. Optic nerve coloboma associated with renal disease. Am J Med Genet 1988; 29:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/15\">",
"      Torban E, Eccles MR, Favor J, Goodyer PR. PAX2 suppresses apoptosis in renal collecting duct cells. Am J Pathol 2000; 157:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/16\">",
"      Porteous S, Torban E, Cho NP, et al. Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice. Hum Mol Genet 2000; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/17\">",
"      Schimmenti LA, Cunliffe HE, McNoe LA, et al. Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet 1997; 60:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/18\">",
"      Fletcher J, Hu M, Berman Y, et al. Multicystic dysplastic kidney and variable phenotype in a family with a novel deletion mutation of PAX2. J Am Soc Nephrol 2005; 16:2754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/19\">",
"      Eccles MR, Schimmenti LA. Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations. Clin Genet 1999; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/20\">",
"      Fraser FC, Ling D, Clogg D, Nogrady B. Genetic aspects of the BOR syndrome--branchial fistulas, ear pits, hearing loss, and renal anomalies. Am J Med Genet 1978; 2:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/21\">",
"      Melnick M, Bixler D, Silk K, et al. Autosomal dominant branchiootorenal dysplasia. Birth Defects Orig Artic Ser 1975; 11:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/22\">",
"      Rodr&iacute;guez Soriano J. Branchio-oto-renal syndrome. J Nephrol 2003; 16:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/23\">",
"      Abdelhak S, Kalatzis V, Heilig R, et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997; 15:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/24\">",
"      Xu PX, Adams J, Peters H, et al. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999; 23:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/25\">",
"      Hoskins BE, Cramer CH, Silvius D, et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007; 80:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/26\">",
"      Kochhar A, Orten DJ, Sorensen JL, et al. SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR. Hum Mutat 2008; 29:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/27\">",
"      Ruf RG, Xu PX, Silvius D, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004; 101:8090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/28\">",
"      Chen A, Francis M, Ni L, et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 1995; 58:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/29\">",
"      Salomon R, Tellier AL, Attie-Bitach T, et al. PAX2 mutations in oligomeganephronia. Kidney Int 2001; 59:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/30\">",
"      Nishimoto K, Iijima K, Shirakawa T, et al. PAX2 gene mutation in a family with isolated renal hypoplasia. J Am Soc Nephrol 2001; 12:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/31\">",
"      Weber S, Moriniere V, Kn&uuml;ppel T, et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol 2006; 17:2864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/32\">",
"      Thomas R, Sanna-Cherchi S, Warady BA, et al. HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort. Pediatr Nephrol 2011; 26:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/33\">",
"      Klare B, Geiselhardt B, Wesch H, et al. Radiological kidney size in childhood. Pediatr Radiol 1980; 9:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/34\">",
"      Han BK, Babcock DS. Sonographic measurements and appearance of normal kidneys in children. AJR Am J Roentgenol 1985; 145:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/35\">",
"      Dudley CR, Keavney B, Stratton IM, et al. U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/36\">",
"      van Essen GG, Rensma PL, de Zeeuw D, et al. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/37\">",
"      Broyer M, Soto B, Gagnadoux MF, et al. Oligomeganephronic renal hypoplasia. Adv Nephrol Necker Hosp 1997; 26:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/38\">",
"      Shimamura T, Morrison AB. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 1975; 79:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10935/abstract/39\">",
"      Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989; 13:443.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6083 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-2.133.93.82-3DA446CC7F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10935=[""].join("\n");
var outline_f10_43_10935=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOLOGY AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Vascular abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Genetic mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Renal-coloboma syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Branchio-oto-renal syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Isolated renal hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Neonate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      First year of life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      After one year of life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ultrasonographic or radiographic findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      COURSE OF RENAL FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Patients with renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6083\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6083|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/28/18889\" title=\"picture 1\">",
"      Renal hypoplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13206?source=related_link\">",
"      Antihypertensive therapy and progression of chronic kidney disease: Experimental studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=related_link\">",
"      Congenital anomalies and acquired abnormalities of the optic nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12055?source=related_link\">",
"      Congenital anomalies of the ear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27881?source=related_link\">",
"      Growth hormone treatment in children with chronic kidney disease and postrenal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=related_link\">",
"      Overview of congenital anomalies of the kidney and urinary tract (CAKUT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16296?source=related_link\">",
"      Prenatal diagnosis of renal agenesis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_43_10936="Nosocomial viral infections in the neonate";
var content_f10_43_10936=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nosocomial viral infections in the neonate",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10936/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10936/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10936/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10936/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10936/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10936/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10936/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/43/10936/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the published incidence of viral neonatal nosocomial infection is considerably lower than bacterial nosocomial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/1\">",
"     1",
"    </a>",
"    ], significant mortality and morbidity occur in the estimated one percent of infants who acquire a viral infection after admission to the neonatal intensive care unit (NICU) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, and the viruses and their clinical manifestations of neonatal nosocomial viral infection will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of neonatal nosocomial viral infections has probably been underestimated because viral studies are not routinely obtained in neonates. The lack of testing for viral infection is due to the overlap of clinical signs and symptoms of viral infections from other conditions seen in the critically ill neonate, the difficulty in obtaining laboratory confirmation of a viral infection, and the lack of effective therapeutic interventions. Published reports have generally focused upon outbreaks of viral infections in neonatal intensive care unit (NICUs).",
"   </p>",
"   <p>",
"    One retrospective Dutch study provided limited data on the incidence of viral infections in the NICU and the most commonly detected viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/2\">",
"     2",
"    </a>",
"    ]. The overall incidence of viral infections in 5396 neonates admitted to a single NICU was 1 percent between 1992 and 2003. Of the 51 identified viral infections, three were due to intrauterine infections due to rubella, cytomegalovirus (CMV), and herpes simplex; the rest were thought to be acquired after admission to the NICU. The causative viral agents and their frequency included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Enterovirus and parechovirus &ndash; 20 cases (39 percent)",
"     </li>",
"     <li>",
"      Respiratory syncytial virus (RSV) &ndash; 15 cases (29 percent)",
"     </li>",
"     <li>",
"      Rotavirus &ndash; 5 cases (10 percent)",
"     </li>",
"     <li>",
"      CMV &ndash; 3 cases (6 percent)",
"     </li>",
"     <li>",
"      Parainfluenza virus &ndash; 2 cases (4 percent)",
"     </li>",
"     <li>",
"      Adenovirus &ndash; 2 cases (4 percent)",
"     </li>",
"     <li>",
"      One case each of rhinovirus infection and rubella infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data regarding nosocomial infections of neonates cared for in the NICU setting collected from the National Nosocomial Infections Surveillance system from 1986 to 1994 demonstrated that viral agents caused 5 percent of the nosocomial infections that affected the eyes, ear, nose and throat, and 30 percent of gastrointestinal infections (predominantly due to rotavirus) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/1\">",
"     1",
"    </a>",
"    ]. The results of this study probably underestimated the contribution of viruses to nosocomial infections because viral causes were not determined for other sites of infection and these data were collected prior to the greater availability of rapid and more sensitive diagnostic testing, such as polymerase chain reaction (PCR) and immunofluorescence (IFA) assays [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential higher incidence of viral infection was illustrated by a prospective surveillance study in two NICUs that found 52 percent of 50 preterm infants &lt;33 weeks gestation screened twice weekly during their hospitalization had one or more viruses detected in their nasopharyngeal specimens using a multiplex polymerase chain reaction assay [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/3\">",
"     3",
"    </a>",
"    ]. Infants who had a positive test for a respiratory virus had a longer length of stay (70 versus 35 days) and ventilatory support (51 versus 13 days), and were more likely to develop bronchopulmonary dysplasia than infants without viral detection. The high frequency of viral detection and its associated consequences suggest that infection was present despite the absence of the usual clinical indicators of infection in many of the infants. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Respiratory viruses'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal nosocomial viral infections are generally dependent upon the following methods of viral transmission:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Droplet spread from the respiratory tract of infected adults or infants",
"     </li>",
"     <li>",
"      Carriage of the organism from the hands of hospital personnel from infected individuals",
"     </li>",
"     <li>",
"      Contaminated medical equipment or supplies including blood products, which can transmit CMV, hepatitis B and C, human immunodeficiency virus (HIV)",
"     </li>",
"     <li>",
"      Breast milk from infected mothers may transmit CMV, HIV, herpes simplex virus (HSV), and human T cell lymphotropic virus type 1 and 2",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Viral infections may also be vertically transmitted from an infected mother either in utero or during delivery. HIV, hepatitis B and C, CMV, and HSV are more likely to be caused by vertical transmission and are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/63/37881?source=see_link\">",
"     \"Hepatitis viruses and the newborn: Clinical manifestations and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link\">",
"     \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=see_link\">",
"     \"Genital herpes simplex virus infection and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link&amp;anchor=H3#H3\">",
"     \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Epidemiology and transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large number of viral agents cause infections in patients admitted to the neonatal intensive care unit (NICU). These can be generally separated into those that present with respiratory or gastrointestinal disease, or in the case of enterovirus with overwhelming, systemic sepsis-like illness, which is frequently fatal.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respiratory disease &ndash; Viruses that commonly cause neonatal respiratory disease include respiratory syncytial virus, parainfluenza virus, influenza, adenovirus, and coronavirus. The clinical manifestations of these viruses vary, ranging from mild upper respiratory tract disease (ie, coughing, rhinorrhea, or sneezing) to severe lower respiratory tract disease (eg, pneumonia), which may require mechanical ventilation. In some cases, these viruses will present as a sepsis-like illness, which may result in significant morbidity and mortality.",
"     </li>",
"     <li>",
"      Gastrointestinal disease &ndash; Rotavirus is the primary viral agent that causes gastroenteritis in the newborn. Enterovirus and adenovirus are less frequently reported causes of neonatal enteric infections. Infected infants may be asymptomatic or have varying clinical manifestations that range from increased stool frequency to watery, hemorrhagic diarrhea. Serious complications including necrotizing enterocolitis may occur.",
"     </li>",
"     <li>",
"      Systemic disease &ndash; Enterovirus, in particular, may present as a severe and fulminant sepsis-like illness or as",
"      <span class=\"nowrap\">",
"       meningitis/encephalitis.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The neonatal clinical manifestations of the more common viruses will be reviewed here. For each of these viruses, a more extensive discussion of the clinical manifestations in older patients, diagnosis, microbiology, and treatment is found separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Respiratory viruses",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Respiratory syncytial virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) is the most common respiratory infection in the neonate [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ]. It is a single-stranded, negative-sense RNA virus and a member of the Paramyxoviridae family. Two subtypes, A and B, are simultaneously present in most outbreaks, with subtype A typically causing more severe disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H10#H10\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The neonatal clinical manifestations vary from mild upper respiratory symptoms of rhinorrhea, congestion, and cough to severe lower tract disease including pneumonia that may require mechanical ventilation or result in death [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/4,6,7\">",
"     4,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the previously mentioned retrospective study, 15 neonates acquired RSV after admission to the neonatal intensive care unit (NICU), of whom the majority were premature infants. The median age of onset of symptoms was 21 days of age, and 12 of the infants required mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/2\">",
"     2",
"    </a>",
"    ]. Smaller case series have reported similar outcomes of increased risk of severe respiratory disease in premature infants, generally requiring mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/4,6-8\">",
"     4,6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Isolated outbreaks of RSV have been reported in the NICU setting, which do not appear to correspond with the seasonal variation of RSV seen in the community [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/4,6-9\">",
"     4,6-9",
"    </a>",
"    ]. In one report, concurrent outbreaks of RSV and echovirus 7 infections occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transmission of RSV is primarily by inoculation of nasopharyngeal or ocular mucous membranes after contact with virus-containing secretions or fomites. RSV can survive for several hours on the hands and fomites. Hand washing and contact precautions are therefore important measures to prevent nosocomial RSV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/4\">",
"     4",
"    </a>",
"    ]. Prompt diagnosis of RSV by rapid diagnostic immunofluorescent testing can allow implementation of infection control measures to prevent further spread of RSV in the NICU [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H11#H11\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Transmission'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H25#H25\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After discharge, infants with a history of prematurity, congenital heart disease, chronic lung disease or bronchopulmonary disease,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunodeficiencies are at increased risk of developing severe RSV infections (ie, lower respiratory tract disease). The American Academy of Pediatrics (AAP) recommends immunoprophylaxis with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/0/40964?source=see_link\">",
"     palivizumab",
"    </a>",
"    for infants with an increased risk of severe RSV infection. Prophylactic use of palivizumab in the neonates cared for in the NICU has also been suggested but there are no data to support its use in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link&amp;anchor=H104278856#H104278856\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Immunoprophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Parainfluenza virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both sporadic cases and outbreaks of parainfluenza have been reported of infants cared for in the NICU [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/2,11-13\">",
"     2,11-13",
"    </a>",
"    ]. PIV is a single-stranded, enveloped RNA virus belonging to the genus paramyxovirus in the Paramyxoviridae family. Although there are four major serologic types that cause disease in humans, parainfluenza type 3 is the type most often implicated in neonatal nosocomial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/11,12,14-17\">",
"     11,12,14-17",
"    </a>",
"    ]. It closely mimics RSV in clinical manifestations, and is the second most common viral cause of pneumonia and bronchiolitis in infants and young children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=see_link&amp;anchor=H10#H10\">",
"     \"Parainfluenza viruses in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations based upon reports of parainfluenza type 3 outbreaks in the NICU, and intermediate care and normal nursery settings vary from mild upper respiratory tract symptoms (cough and coryza) to severe lower respiratory tract disease and apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/11,12,14\">",
"     11,12,14",
"    </a>",
"    ]. Premature infants have an atypical course and often present with recurrent apneic episode, sepsis-like illness, or unexplained worsening of bronchopulmonary dysplasia (BPD) with an increasing oxygen requirement and wheezing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/11,16\">",
"     11,16",
"    </a>",
"    ]. Newborn infants with severe lower respiratory tract disease may also require mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/11,14,15\">",
"     11,14,15",
"    </a>",
"    ]. Parainfluenza viral type 3 infection prolongs the duration of oxygen requirement in premature infants with BPD and the length of hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A concomitant outbreak of parainfluenza virus type 3 and RSV was reported in one newborn nursery that affected 20 of 34 infants over a three-week time period [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/14\">",
"     14",
"    </a>",
"    ]. In 14 of the 20 symptomatic infants, RSV alone was isolated in seven patients, parainfluenza virus type 3 alone in five, and both viruses in two infants. There were no differences in symptoms (which included rhinorrhea, cough, apnea, pneumonia, and fever) among the three groups of infants.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, and clinical manifestations in older infants and children with parainfluenza viral infection are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=see_link&amp;anchor=H10#H10\">",
"     \"Parainfluenza viruses in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Influenza virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza viruses are orthomyxoviruses with three types (A, B, and C). Influenza virus type A has been reported as a cause of nosocomial respiratory infection in outbreaks in the NICU [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/19-24\">",
"     19-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In neonates, the clinical manifestations of influenza type A generally present with mild to moderate signs and symptoms that are primarily due to upper rather than lower respiratory tract disease [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/19-23\">",
"     19-23",
"    </a>",
"    ]. Other findings may include apnea, fever, and gastrointestinal symptoms.",
"   </p>",
"   <p>",
"    Clinical findings are illustrated in a large case series of 30 neonates with nosocomial influenza A infection identified from a cohort of 95 newborns during two outbreaks of influenza A in a Spanish NICU [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/21\">",
"     21",
"    </a>",
"    ]. Patients were detected by a positive indirect immunofluorescence antibody (IFA) screen of nasopharyngeal secretions. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical symptoms were noted in 22 infants and 8 were asymptomatic. Twenty-eight of the patients were premature, and in 14 the gestational age was less than 32 weeks.",
"     </li>",
"     <li>",
"      Respiratory symptoms were seen in 19 patients. Mild upper respiratory symptoms (cough, sneezing, and rhinorrhea) were seen in eight patients that remitted in two to three days. Eleven patients had mild respiratory distress that required supplementary oxygen or an increase in oxygen concentration. In these patients, the mean duration of symptoms was eight days (range 3 to 10 days).",
"     </li>",
"     <li>",
"      Four patients had gastrointestinal findings, which included poor feeding, vomiting,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abdominal distension. There was no evidence of necrotizing enterocolitis.",
"     </li>",
"     <li>",
"      There were no deaths or long-term complication related to the infection.",
"     </li>",
"     <li>",
"      Infants who developed infections had lower birth weight and shorter gestational age than the noninfected group.",
"     </li>",
"     <li>",
"      Two parents and one nurse were identified as possible sources of the outbreak.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Adenovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenoviruses are double-stranded DNA viruses with over 50 serotypes that cause disease in humans. Adenoviruses cause 5 to 10 percent of all febrile illnesses in infants and young children. Most individuals have serologic evidence of a prior adenoviral infection by the age of 10. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Outbreaks of adenovirus infection in the NICU have been reported that present with either new or worsening respiratory disease, or keratoconjunctivitis. In one reported NICU outbreak of adenovirus type 8, 7 of 11 infected neonates had onset of new respiratory symptoms or required increased respiratory support [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/25\">",
"     25",
"    </a>",
"    ]. Two patients had conjunctivitis.",
"   </p>",
"   <p>",
"    In another report, 21 of 333 infants cared for in a NICU were infected with adenovirus type 30, of whom seven developed pneumonia, seven conjunctivitis, one patient had both pneumonia and conjunctivitis, another only upper respiratory symptoms, and five patients were asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/26\">",
"     26",
"    </a>",
"    ]. Six patients died. Patients with severe bronchopulmonary dysplasia requiring mechanical ventilation were more likely to develop pneumonia and die.",
"   </p>",
"   <p>",
"    Other outbreaks have reported only eye involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Other respiratory viral agents",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coronavirus &ndash; Coronaviruses are large, enveloped, positive stranded RNA viruses whose name is derived from their characteristic crown-like appearance in electron micrographs. Coronaviruses are important human pathogens and are associated with up to one-third of community-acquired upper respiratory infections. In the 1990s, the newly developed viral tests (eg, IFA screening and PCR testing) made it possible to detect these pathogens rapidly and reliably. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=see_link\">",
"       \"Coronaviruses\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In one prospective study of 40 infants in a French NICU, IFA screening of tracheal or nasopharyngeal specimens for viral infections was positive for coronavirus, influenza, and adenovirus in 10, 2, and 1 samples, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/29\">",
"       29",
"      </a>",
"      ]. Symptoms in patients infected with coronavirus included bradycardia, apnea, hypoxia, fever, or abdominal distension. In two cases, chest radiography demonstrated diffuse infiltrates. The authors concluded that testing for coronavirus should be included in infants with respiratory symptoms because this virus appears to be a common cause of neonatal nosocomial infections.",
"     </li>",
"     <li>",
"      Human metapneumovirus &ndash; In 2001, investigators from the Netherlands discovered a new member of the Paramyxoviridae family, which includes RSV, the genus Metapneumovirus. The first representative of this genus to cause infection in humans has been called the human metapneumovirus (hMPV). Data suggest this virus has been responsible for infection over at least 50 years with a worldwide distribution. Since its discovery, hMPV has been shown to be a frequent and important cause of respiratory infection in children. However, as of 2008, the incidence of nosocomial hMPV infection in the NICU setting has yet to be determined. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=see_link\">",
"       \"Human metapneumovirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rhinovirus &ndash; A prospective study from an Austrian neonatal care facility identified rhinovirus as the causative agent for suspected respiratory infection in 16 of 106 preterm infants who were screened for viral infection by polymerase chain reaction [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/30\">",
"       30",
"      </a>",
"      ]. Other viruses included in the screening were influenza A and B, influenza H1N1, RSV, human metapneumovirus, and adenovirus. Clinical findings of the infants with rhinoviral infection were nasal discharge, congestion, and increased work of breathing. Twelve patients received respiratory support (ie, supplemental oxygen, nasal continuous positive airway pressure or mechanical ventilation). Metapneumovirus was also detected in one other patient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Gastrointestinal viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although other viruses, such as enterovirus and adenovirus, can cause gastroenteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/25,26,31,32\">",
"     25,26,31,32",
"    </a>",
"    ], rotavirus is responsible for the vast majority of viral nosocomial gastrointestinal infections in the newborn [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enteric viruses are spread rapidly among hospitalized infants generally via the fecal-oral route. The principal mode of transmission is through health care workers, contaminated equipment,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fomites [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Rotavirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rotavirus is a double-stranded RNA virus, which belongs to the Reoviridae family. It is the primary viral agent that causes nosocomial gastroenteritis in the neonate. In the previously mentioned survey by the National Nosocomial Infections Surveillance system, rotavirus was isolated in 96 percent of cases of viral enteric infections of infants cared for in high-risk nurseries [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/1\">",
"     1",
"    </a>",
"    ]. Neonatal rotavirus infection has been reported as a frequent occurrence worldwide. The incidence of detected virus is particularly high in developing countries. As an example, the reported incidence of rotavirus in Indian nurseries ranged from 43 to 78 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of neonatal rotavirus infection increases when the virus is epidemic in the community. This was illustrated in one study that demonstrated an increase in the rate of rotavirus detected in stools from 11 percent at baseline to 21 percent during periods of community epidemics [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the neonate, rotavirus infection is often mild or asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/34,36,38,39\">",
"     34,36,38,39",
"    </a>",
"    ]. Gastrointestinal symptoms range from increased frequency of stools [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/37\">",
"     37",
"    </a>",
"    ] to watery, mucoid, and",
"    <span class=\"nowrap\">",
"     /or",
"    </span>",
"    hemorrhagic diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/40\">",
"     40",
"    </a>",
"    ]. Other findings include presence of gastric residuals, abdominal distention, intestinal dilation, ileus, and emesis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/39\">",
"     39",
"    </a>",
"    ]. In severe cases of infection, dehydration, electrolyte abnormalities, and acidosis may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/33\">",
"     33",
"    </a>",
"    ]. Reported complications include necrotizing enterocolitis (NEC), bowel perforation, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/38,40-43\">",
"     38,40-43",
"    </a>",
"    ]. Although preterm infants and those with immunodeficiencies are at increased risk for severe disease and complications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/44\">",
"     44",
"    </a>",
"    ], NEC has been linked to rotavirus infections in otherwise healthy term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transplacental antibody from previously infected mothers appears to provide some protection to the neonate. This may contribute to the mild or asymptomatic presentation of infected infants who are identified by positive antigen screening of their stools. Premature infants are at the greatest risk of severe infection because of the decrease in maternal antibody transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Recurrent infections are usually mild or asymptomatic because of protective immunity following the initial infection.",
"   </p>",
"   <p>",
"    Rotavirus vaccination has been shown to reduce the incidence of RSV gastroenteritis in infants. The following two vaccines are currently available in the United States and can be administered to premature infants including those born with a gestational age less than 32 weeks, who are clinically stable, at least 6 weeks old, and are going to be or have been discharged from the nursery (",
"    <a class=\"graphic graphic_table graphicRef70478 \" href=\"UTD.htm?20/22/20844\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=see_link\">",
"     \"Rotavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pentavalent human-bovine rotavirus reassortant vaccine (RV5, PRV, RotaTeq)",
"     </li>",
"     <li>",
"      Monovalent attenuated human",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/29/33237?source=see_link\">",
"       rotavirus vaccine",
"      </a>",
"      (RV1, HRV, Rotarix)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Human milk appears to be associated with milder disease in infected infants [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. In one study, none of the breastfed infants who contracted rotavirus developed symptomatic diarrheal illness [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Sepsis-like illness",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Enterovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The human neonate is uniquely susceptible to enterovirus disease. Although many enterovirus serotypes cause the same self-limited clinical syndromes in neonates as they do in older persons (eg, aseptic meningitis, exanthems), some serotypes are capable of producing fulminant, sepsis-like illness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <span class=\"nowrap\">",
"     encephalitis/meningitis",
"    </span>",
"    in the newborn infant that may be fatal. In the previously mentioned Dutch study, the 20 cases of enteroviral infections in infants admitted to their NICU were all severe presenting with a sepsis-like illness [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10936/abstract/2\">",
"     2",
"    </a>",
"    ]. Twelve of the patients had clinical symptoms of meningitis. Two of the patients died and three had significant sequelae (ie, poor neurodevelopmental outcome, and heart or liver failure).",
"   </p>",
"   <p>",
"    A more complete description of neonatal enteroviral infection is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\", section on 'Infections in neonates'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nosocomial viral infections are reported to occur in one percent in all infants admitted to the neonatal intensive care unit (NICU) resulting in significant neonatal morbidity and mortality. However, this rate probably underestimates the incidence of viral infections because viral studies are not routinely obtained in neonates and it is often difficult to obtain laboratory confirmation of a viral infection. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neonatal nosocomial viral infections are primarily dependent upon transmission of the organisms through droplet spread, or direct transmission of the organism from infected adults or the contaminated hands of health care providers, or contaminated medical equipment or supplies. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viral agents that cause infections in the neonates can be separated into those that generally present with respiratory disease, gastrointestinal disease, or sepsis-like illness. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology and clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viruses that cause neonatal respiratory disease include respiratory syncytial virus (the most common of the respiratory viruses), parainfluenza virus, influenza virus, adenovirus, and coronavirus.",
"     </li>",
"     <li>",
"      The clinical manifestations of neonatal respiratory viral disease vary ranging from mild upper (ie, coughing, rhinorrhea, or sneezing) to severe lower respiratory tract disease, which may require mechanical ventilation. In some cases, these viruses will present as a sepsis-like syndrome. Premature infants are at increased risk for severe respiratory infection. Infants with respiratory failure or systemic disease are more likely to have significant morbidity and mortality. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Respiratory viruses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although other viruses, such as enterovirus and adenovirus, can cause gastroenteritis, rotavirus is responsible for most of the viral nosocomial enteric infections in the newborn.",
"     </li>",
"     <li>",
"      Neonatal rotavirus infection is often mild or asymptomatic. Gastrointestinal symptoms range from increased frequency of stools to watery, mucoid,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hemorrhagic diarrhea. Premature and immunodeficient infants are more likely to have severe disease and complications, such as intestinal dilation, ileus, fluid and electrolyte abnormalities, acidosis, necrotizing enterocolitis, bowel perforation, and death. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Gastrointestinal viruses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Enteroviral infections may produce a fulminant, sepsis-like illness in the newborn infant that is frequently fatal. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Enterovirus'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6020866\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Jenny L Ravenscroft, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/1\">",
"      Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996; 98:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/2\">",
"      Verboon-Maciolek MA, Krediet TG, Gerards LJ, et al. Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period. Pediatr Infect Dis J 2005; 24:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/3\">",
"      Bennett NJ, Tabarani CM, Bartholoma NM, et al. Unrecognized viral respiratory tract infections in premature infants during their birth hospitalization: a prospective surveillance study in two neonatal intensive care units. J Pediatr 2012; 161:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/4\">",
"      Heerens AT, Marshall DD, Bose CL. Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol 2002; 22:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/5\">",
"      Vieira RA, Diniz EM, Vaz FA. Clinical and laboratory study of newborns with lower respiratory tract infection due to respiratory viruses. J Matern Fetal Neonatal Med 2003; 13:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/6\">",
"      White MP, Mackie PL. Respiratory syncytial virus infection in special care nursery. Lancet 1990; 335:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/7\">",
"      Kilani RA. Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases. J Trop Pediatr 2002; 48:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/8\">",
"      Halasa NB, Williams JV, Wilson GJ, et al. Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 2005; 24:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/9\">",
"      Kang JO, Kim CR. Nosocomial respiratory syncytial virus infection in a newborn nursery. J Korean Med Sci 1997; 12:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/10\">",
"      Wilson CW, Stevenson DK, Arvin AM. A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery. Pediatr Infect Dis J 1989; 8:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/11\">",
"      Ng W, Rajadurai VS, Pradeepkumar VK, et al. Parainfluenza type 3 viral outbreak in a neonatal nursery. Ann Acad Med Singapore 1999; 28:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/12\">",
"      Moisiuk SE, Robson D, Klass L, et al. Outbreak of parainfluenza virus type 3 in an intermediate care neonatal nursery. Pediatr Infect Dis J 1998; 17:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/13\">",
"      Simmonds A, Munoz J, Montecalvo M, et al. Outbreak of parainfluenza virus type 3 in a neonatal intensive care unit. Am J Perinatol 2009; 26:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/14\">",
"      Meissner HC, Murray SA, Kiernan MA, et al. A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr 1984; 104:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/15\">",
"      McCarthy VP, Carlile JR, Reichelderfer PS, Clark JS. Parainfluenza type 3 in newborns. Pediatr Infect Dis J 1987; 6:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/16\">",
"      Singh-Naz N, Willy M, Riggs N. Outbreak of parainfluenza virus type 3 in a neonatal nursery. Pediatr Infect Dis J 1990; 9:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/17\">",
"      Abzug MJ, Beam AC, Gyorkos EA, Levin MJ. Viral pneumonia in the first month of life. Pediatr Infect Dis J 1990; 9:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/18\">",
"      Heidemann SM. Clinical characteristics of parainfluenza virus infection in hospitalized children. Pediatr Pulmonol 1992; 13:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/19\">",
"      Munoz FM, Campbell JR, Atmar RL, et al. Influenza A virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 1999; 18:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/20\">",
"      Cunney RJ, Bialachowski A, Thornley D, et al. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2000; 21:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/21\">",
"      Sagrera X, Ginovart G, Raspall F, et al. Outbreaks of influenza A virus infection in neonatal intensive care units. Pediatr Infect Dis J 2002; 21:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/22\">",
"      Bauer CR, Elie K, Spence L, Stern L. Hong Kong influenza in a neonatal unit. JAMA 1973; 223:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/23\">",
"      Meibalane R, Sedmak GV, Sasidharan P, et al. Outbreak of influenza in a neonatal intensive care unit. J Pediatr 1977; 91:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/24\">",
"      Vij NK, Stryker CC, Esper FP, et al. Influenza A/H1N1/09-10 infections in a NICU during the 2009-2010 H1N1 pandemic. Pediatrics 2011; 128:e1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/25\">",
"      Piedra PA, Kasel JA, Norton HJ, et al. Description of an adenovirus type 8 outbreak in hospitalized neonates born prematurely. Pediatr Infect Dis J 1992; 11:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/26\">",
"      Faden H, Wynn RJ, Campagna L, Ryan RM. Outbreak of adenovirus type 30 in a neonatal intensive care unit. J Pediatr 2005; 146:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/27\">",
"      Birenbaum E, Linder N, Varsano N, et al. Adenovirus type 8 conjunctivitis outbreak in a neonatal intensive care unit. Arch Dis Child 1993; 68:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/28\">",
"      Percivalle E, Sarasini A, Torsellini M, et al. A comparison of methods for detecting adenovirus type 8 keratoconjunctivitis during a nosocomial outbreak in a Neonatal Intensive Care Unit. J Clin Virol 2003; 28:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/29\">",
"      Sizun J, Soupre D, Legrand MC, et al. Neonatal nosocomial respiratory infection with coronavirus: a prospective study in a neonatal intensive care unit. Acta Paediatr 1995; 84:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/30\">",
"      Steiner M, Strassl R, Straub J, et al. Nosocomial rhinovirus infection in preterm infants. Pediatr Infect Dis J 2012; 31:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/31\">",
"      Rodriguez-Baez N, O'Brien R, Qiu SQ, Bass DM. Astrovirus, adenovirus, and rotavirus in hospitalized children: prevalence and association with gastroenteritis. J Pediatr Gastroenterol Nutr 2002; 35:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/32\">",
"      Berner R, Schumacher RF, Hameister S, Forster J. Occurrence and impact of community-acquired and nosocomial rotavirus infections--a hospital-based study over 10 y. Acta Paediatr Suppl 1999; 88:48.",
"     </a>",
"    </li>",
"    <li>",
"     Red Book Atlas of Pediatric Infectious Diseases, 1st ed, American Academy of Pediatrics, Elk Grove Village, IL 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/34\">",
"      Chandran A, Heinzen RR, Santosham M, Siberry GK. Nosocomial rotavirus infections: a systematic review. J Pediatr 2006; 149:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/35\">",
"      Cicirello HG, Das BK, Gupta A, et al. High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Pediatr Infect Dis J 1994; 13:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/36\">",
"      Ramani S, Sowmyanarayanan TV, Gladstone BP, et al. Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India. Pediatr Infect Dis J 2008; 27:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/37\">",
"      Linhares AC, Mascarenhas JD, Gusm&atilde;o RH, et al. Neonatal rotavirus infection in Bel&eacute;m, northern Brazil: nosocomial transmission of a P[6] G2 strain. J Med Virol 2002; 67:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/38\">",
"      Haffejee IE. Neonatal rotavirus infections. Rev Infect Dis 1991; 13:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/39\">",
"      Sharma R, Hudak ML, Premachandra BR, et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J 2002; 21:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/40\">",
"      Dearlove J, Latham P, Dearlove B, et al. Clinical range of neonatal rotavirus gastroenteritis. Br Med J (Clin Res Ed) 1983; 286:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/41\">",
"      Akinci A, Tezi&ccedil; T, G&uuml;r I, et al. Rotavirus diarrhea in newborn infants. Turk J Pediatr 1991; 33:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/42\">",
"      Rotbart HA, Levin MJ, Yolken RH, et al. An outbreak of rotavirus-associated neonatal necrotizing enterocolitis. J Pediatr 1983; 103:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/43\">",
"      Sharma R, Garrison RD, Tepas JJ 3rd, et al. Rotavirus-associated necrotizing enterocolitis: an insight into a potentially preventable disease? J Pediatr Surg 2004; 39:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/44\">",
"      Rotbart HA, Nelson WL, Glode MP, et al. Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr 1988; 112:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/45\">",
"      Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/46\">",
"      Raad II, Sherertz RJ, Russell BA, Reuman PD. Uncontrolled nosocomial rotavirus transmission during a community outbreak. Am J Infect Control 1990; 18:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/47\">",
"      Kilgore PE, Unicomb LE, Gentsch JR, et al. Neonatal rotavirus infection in Bangladesh: strain characterization and risk factors for nosocomial infection. Pediatr Infect Dis J 1996; 15:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/48\">",
"      Bhan MK, Lew JF, Sazawal S, et al. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis 1993; 168:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/49\">",
"      Ramachandran M, Vij A, Kumar R, et al. Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains. Clin Diagn Lab Immunol 1998; 5:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/50\">",
"      Gianino P, Mastretta E, Longo P, et al. Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants. J Hosp Infect 2002; 50:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/51\">",
"      Mastretta E, Longo P, Laccisaglia A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002; 35:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10936/abstract/52\">",
"      Berger R, Hadziselimovic F, Just M, Reigel F. Influence of breast milk on nosocomial rotavirus infections in infants. Infection 1984; 12:171.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5025 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-B32189B1BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10936=[""].join("\n");
var outline_f10_43_10936=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY AND CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Respiratory viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Respiratory syncytial virus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Parainfluenza virus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Influenza virus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Adenovirus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Other respiratory viral agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Gastrointestinal viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Rotavirus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Sepsis-like illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Enterovirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6020866\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5025\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5025|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/22/20844\" title=\"table 1\">",
"      Rotavirus vaccines summary",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=related_link\">",
"      Coronaviruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=related_link\">",
"      Cytomegalovirus infection and disease in newborns, infants, children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=related_link\">",
"      Epidemiology and clinical manifestations of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/14/33001?source=related_link\">",
"      Genital herpes simplex virus infection and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/63/37881?source=related_link\">",
"      Hepatitis viruses and the newborn: Clinical manifestations and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=related_link\">",
"      Human metapneumovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=related_link\">",
"      Parainfluenza viruses in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=related_link\">",
"      Respiratory syncytial virus infection: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=related_link\">",
"      Rotavirus vaccines",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_43_10937="Diagnosis and staging of small bowel neoplasms";
var content_f10_43_10937=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and staging of small bowel neoplasms",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10937/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10937/contributors\">",
"     James C Cusack, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10937/contributors\">",
"     Michael J Overman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10937/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10937/contributors\">",
"     Richard M Goldberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10937/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10937/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/43/10937/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 16, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of tumors, both malignant and benign, may arise within the small intestine. Malignant tumors include adenocarcinomas, carcinoids, stromal tumors, and lymphomas. Benign lesions that may arise in the small bowel include adenomas, leiomyomas, fibromas, and lipomas.",
"   </p>",
"   <p>",
"    The diagnosis and staging of small bowel tumors will be reviewed here. The epidemiology, clinical manifestations, and treatment of the specific types of tumors are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/31/18938?source=see_link\">",
"     \"Epidemiology, clinical features, and types of small bowel neoplasms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/8/21642?source=see_link\">",
"     \"Treatment of small bowel neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of small bowel neoplasms may include one or more of the following: pain, obstruction, bleeding, anorexia, weight loss, perforation, or in the case of a duodenal primary, jaundice. Malignant tumors are more likely to be symptomatic as compared to benign lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/31/18938?source=see_link&amp;anchor=H11#H11\">",
"     \"Epidemiology, clinical features, and types of small bowel neoplasms\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The variable nature of the presenting symptoms, combined with the lack of physical findings, can contribute to a delay in diagnosis in many cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/1\">",
"     1",
"    </a>",
"    ]. In one study, failure to obtain a proper diagnostic test or misinterpretation of test results accounted for delays of 8 and 12 months, respectively; by comparison, the estimated diagnostic delay due to the patient's failure to report symptoms was less than two months [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/2\">",
"     2",
"    </a>",
"    ]. As prognosis is closely linked to disease extent for all of the major malignant small bowel tumors, early detection and treatment can contribute to a favorable outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Because of the vagueness and nonspecificity of the presenting symptoms, a high index of suspicion is essential for early diagnosis and treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients whose symptoms are such that a small bowel tumor is part of the differential diagnosis should undergo a complete history, physical examination, and screening for fecal occult blood. A minimum laboratory work-up should include a complete blood count, measurement of serum electrolytes, and liver function tests.",
"   </p>",
"   <p>",
"    The specific components of the diagnostic and staging workup are addressed in the following sections. There is no single method that is best for imaging of the small intestine in a patient with a suspected small bowel tumor. The choices are radiographic (CT scan, small bowel series, enteroclysis) or endoscopic (wireless capsule endoscopy, push enteroscopy, double-balloon endoscopy).",
"   </p>",
"   <p>",
"    Depending on the clinical scenario, multiple tests may be needed to adequately evaluate the small intestine. The best testing strategy and sequence of diagnostic tests are not established, and there is debate as to how much diagnostic workup is adequate to exclude a small bowel tumor. If the suspicion of a small bowel tumor is high, one school of thought holds that at least two imaging methods (eg, wireless video capsule endoscopy followed by double balloon enteroscopy) should be used to exclude a small bowel malignancy. However, there is no consensus on this issue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17178?source=see_link\">",
"     \"Wireless video capsule endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/4/24649?source=see_link\">",
"     \"Overview of deep small bowel enteroscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Radiographic imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple radiographic investigations are available for patients suspected of having a small bowel tumor (",
"    <a class=\"graphic graphic_table graphicRef62087 \" href=\"UTD.htm?7/39/7804\">",
"     table 1",
"    </a>",
"    ). Plain abdominal films are generally of limited value unless bowel obstruction is suspected, a condition which is a nonspecific finding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     UGI/SBFT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper GI series with small bowel follow through",
"    <span class=\"nowrap\">",
"     (UGI/SBFT)",
"    </span>",
"    may show a mass lesion, mucosal defect, or intussusception. In older series, the sensitivity was approximately 50 to 60 percent for the detection of advanced small bowel tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. In one report of 89 patients with small bowel tumors,",
"    <span class=\"nowrap\">",
"     UGI/SBFT",
"    </span>",
"    was diagnostic in 57 percent of malignant tumors but only 25 percent of primary benign tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is frequently obtained when evaluating vague or indeterminate abdominal complaints. CT is able to detect abnormalities in approximately 70 to 80 percent of patients with small bowel tumors (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73944 \" href=\"UTD.htm?33/0/33794\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Besides demonstrating the primary tumor, CT scans are of critical importance for appropriate evaluation of extraintestinal spread to distant sites and involvement of regional lymph nodes. In addition, specific radiographic features may suggest the histologic diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, for carcinoid tumors, an abdominal CT with intravenous and oral contrast has a sensitivity of 77 to 87 percent for identifying at least one of the manifestations of a carcinoid tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. This may be the primary tumor, mesenteric stranding due to tumor involvement and a fibrotic response (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78186 \" href=\"UTD.htm?42/57/43921\">",
"     image 2",
"    </a>",
"    ), liver metastases (which are invariably present when carcinoid syndrome arises from a gut primary), or mesenteric lymph node enlargement. Gadolinium-enhanced MRI of the liver is more sensitive than abdominal CT for evaluating both the presence and extent of liver metastases in patients with a carcinoid tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6665?source=see_link\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, imaging, even with combinations of CT, MRI, and radionuclide scintigraphy, tends to underestimate the extent of peritoneal, mesenteric, and hepatic metastatic disease in patients with small bowel carcinoid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/17\">",
"     17",
"    </a>",
"    ]. Accurate staging might be best achieved at the time of laparotomy. The utility of radionuclide scintigraphy in tumor localization is discussed below. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Tumor localization by octreotide and MIBG scans'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Angiography and radionuclide scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with active bleeding, angiography or radionuclide scanning with technetium (99mTc) sulfur colloid or 99mTc pertechnate-labeled autologous red blood cells can help to localize the site of bleeding. In addition, for certain tumors, most notably carcinoid and leiomyosarcoma, a distinctive tumor blush may be seen on angiography. However, these tests are rarely indicated in the initial diagnostic workup. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/39/31352?source=see_link\">",
"     \"Evaluation of obscure gastrointestinal bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Enteroclysis and enterography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteroclysis is a double-contrast radiographic study that is performed by passing a tube into the proximal small bowel and injecting both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/28/29123?source=see_link\">",
"     methylcellulose",
"    </a>",
"    . This technique is superior to",
"    <span class=\"nowrap\">",
"     UGI/SBFT",
"    </span>",
"    to detect malignant small bowel tumors. As an example, in one study, the sensitivity of enteroclysis for picking up a malignant small bowel tumors was 90 percent, versus 33 percent for conventional",
"    <span class=\"nowrap\">",
"     UGI/SBFT",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/7\">",
"     7",
"    </a>",
"    ]. One potential downside is that enteroclysis usually fails to detect flat infiltrating lesions.",
"   </p>",
"   <p>",
"    Newer techniques that are performed in conjunction with CT",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    MRI (termed CT or MR enterography rather than enteroclysis) appear more promising [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/5,6,19-24\">",
"     5,6,19-24",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24724378\">",
"    <span class=\"h4\">",
"     CT enterography",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT enterography is an alternative to enteroclysis that does not require placement of a nasogastric tube for contrast administration; it is better tolerated by patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/25\">",
"     25",
"    </a>",
"    ]. Patients ingest a large volume of an attenuation-neutral enteric contrast material (often low concentration",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    or water). This results in distension of the small bowel lumen with a contrast agent that does not interfere with the ability to visualize the lumen and the bowel wall with CT.",
"   </p>",
"   <p>",
"    In one of the largest series, 219 patients with a clinical suspicion for small bowel neoplasms and a negative upper and lower endoscopic evaluation underwent contrast and water-enhanced multidetector CT enterography [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/23\">",
"     23",
"    </a>",
"    ]. Positive findings were compared with the results of surgical exploration or endoscopic procedures, while negative results were correlated with the results of surgery, intraoperative enteroscopy, capsule endoscopy, or clinical follow-up.",
"   </p>",
"   <p>",
"    A small bowel mass was demonstrated in 55 patients, which was confirmed in 50 (ie, there were five false-positive studies). These included two masses diagnosed as fold thickening at intraoperative enteroscopy, two small bowel polyps, and one 18 mm hyperintense mass, with all three cases confirmed as normal mucosa at surgery or preoperative enteroscopy.",
"   </p>",
"   <p>",
"    Of the 164 patients with a normal result, a small bowel tumor was later found in nine. The sensitivity, specificity, negative predictive value, and positive predictive value were 85, 97, 95, and 91 percent, respectively. Whether similar results can be achieved at other centers is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24724393\">",
"    <span class=\"h4\">",
"     MR enterography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not as widely available as CT enterography, MR enterography is emerging as an accurate technique for diagnosis and exclusion of a small bowel neoplasm [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/5,26\">",
"     5,26",
"    </a>",
"    ]. The largest study included 91 symptomatic patients with either suspected or established small bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/5\">",
"     5",
"    </a>",
"    ]. The studies were independently interpreted by two different gastrointestinal radiologists who were blinded as to the clinical history. Eighty-six of the studies were correctly interpreted (diagnostic accuracy 95 percent); a small bowel neoplasm was confirmed histopathologically (by endoscopy or surgery) in 32. The sensitivity, specificity, positive predictive value, and negative predictive value were 94, 95, 91, and 97 percent, respectively for one of the radiologists, and 91, 97, 94, and 95 percent, respectively, for the second radiologist. The extrapolation of these results to the general population is limited by the small size and retrospective nature of the study, and the much higher prevalence of small bowel tumors in this highly select cohort.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7028823\">",
"    <span class=\"h3\">",
"     PET and integrated PET/CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET scanning with the radiotracer 18-F-deoxyglucose (FDG), particularly integrated",
"    <span class=\"nowrap\">",
"     PET/CT,",
"    </span>",
"    may be useful for initial diagnosis of small bowel neoplasms, staging, evaluating response to treatment, and restaging at the time of suspected disease recurrence. Utility varies according to",
"    <span class=\"nowrap\">",
"     histology.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1418955691\">",
"    <span class=\"h4\">",
"     Adenocarcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET/CT",
"    allows primary lesion detection of small bowel adenocarcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/27-29\">",
"     27-29",
"    </a>",
"    ], although sensitivity compared with other imaging methods has not been systematically studied. The ability of",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    to detect local and distant metastatic disease has not been formally evaluated. However, it seems reasonable to extrapolate from the experience from colorectal adenocarcinoma, in which PET scanning is useful as an adjunct to other imaging modalities for localizing sites of disease recurrence in patients with a rising CEA posttreatment and nondiagnostic conventional imaging, and for evaluation of patients who are thought to be candidates for resection of isolated colorectal cancer liver metastases, in whom the routine use of PET prior to attempted resection reduces the number of nontherapeutic laparotomies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'PET scans'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1418955698\">",
"    <span class=\"h4\">",
"     Lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of data regarding the use of PET in the evaluation of patients with small bowel lymphoma. Of the histologies most commonly seen in the small intestine, diffuse large B cell lymphoma (DLBCL), mantle cell lymphoma, Burkitt lymphoma, and enteropathy associated T cell lymphoma are typically FDG-avid [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/30\">",
"     30",
"    </a>",
"    ]. In contrast, marginal zone lymphoma and follicular lymphoma have variable FDG-avidity. Many clinicians incorporate PET into the pretreatment evaluation of patients with DLBCL of the GI tract, but its utility in other subtypes is controversial. This issue is addressed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical presentation and diagnosis of primary gastrointestinal lymphomas\", section on 'Lymphoma of the small intestine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1418955706\">",
"    <span class=\"h4\">",
"     Sarcoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET is highly sensitive (86 to 100 percent) for detecting tumors with a high glucose metabolism, such as GIST, and PET can be useful for detecting an unknown primary site or resolving ambiguities from CT (eg, when the CT findings are inconclusive or inconsistent with the clinical findings). However, because of limitations in specificity, PET has not replaced CT as the initial imaging modality of choice in patients suspected of having a GI tract mesenchymal tumor.",
"   </p>",
"   <p>",
"    While a baseline PET may be indicated for patients in whom PET will be used to monitor the response to therapy with a tyrosine kinase inhibitor, nearly all the data obtained by PET scan imaging can be found in a good quality traditional IV contrasted CT scan, with superior anatomic definition. A clinical scenario where baseline and follow-up PET scan might prove useful is a borderline resectable GIST (or a potentially resectable tumor that requires extensive organ disruption) in which there is a narrow window for moving to alternative therapy (eg, resection or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    ) if",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/1/17434?source=see_link\">",
"     imatinib",
"    </a>",
"    is ineffective. An FDG-PET response, which is characterized by a marked decrease in the glycolytic metabolism of GISTs, can be seen as early as 24 hours after treatment is initiated. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/58/34730?source=see_link&amp;anchor=H3#H3\">",
"     \"Tyrosine kinase inhibitor therapy for advanced gastrointestinal stromal tumors\", section on 'Assessing response to therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/34/33321?source=see_link&amp;anchor=H8#H8\">",
"     \"Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors\", section on 'Neoadjuvant therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1418955714\">",
"    <span class=\"h4\">",
"     Carcinoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoid tumors are typically non-FDG avid, although newer tracers for functional imaging show some promise. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6665?source=see_link&amp;anchor=H7#H7\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring\", section on 'Other functional imaging methods'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=see_link&amp;anchor=H31868311#H31868311\">",
"     \"Diagnosis of the carcinoid syndrome and tumor localization\", section on 'Functional PET imaging techniques'",
"    </a>",
"    .)",
"    <strong>",
"    </strong>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Endoscopic techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advantages and disadvantages of several endoscopic methods for evaluation of the small bowel are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef62087 \" href=\"UTD.htm?7/39/7804\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Upper endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard upper endoscopy is capable of reaching only the proximal duodenum. It may be adequate if a proximal small bowel tumor is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Wireless video capsule endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wireless video capsule endoscopy (VCE) provides a noninvasive means of visualizing the entire small bowel. It has become a standard diagnostic approach for patients with obscure gastrointestinal bleeding. This relatively new technology has already supplanted some of the older techniques, such as enteroclysis, in the workup of small bowel tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17178?source=see_link\">",
"     \"Wireless video capsule endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The utility of VCE in diagnosing small bowel tumors was demonstrated in a retrospective study of 562 patients who underwent the procedure at Mount Sinai Medical Center from 2001 to 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/31\">",
"     31",
"    </a>",
"    ]. Indications for endoscopy were obscure gastrointestinal bleeding (79 percent), chronic abdominal pain (5 percent), or search for carcinoid primary (4 percent). A total of 50 patients were diagnosed with small bowel tumors, of which 48 percent were malignant. Among patients who were younger than 50 years old undergoing VCE for obscure gastrointestinal bleeding, nine (13 percent) had a small bowel tumor. There was one false-positive result (which prompted a negative surgical exploration), but the number of false negative studies could not be ascertained as information on outcomes among patients who had a negative VCE was not available.",
"   </p>",
"   <p>",
"    Information on the false negative rate of VCE was provided in a meta-analysis of 310 patients from 24 studies in which VCE was compared prospectively to a standard diagnostic workup (push enteroscopy in 220 patients, small-bowel series 140 patients, or colonoscopy with ileoscopy in 90 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/32\">",
"     32",
"    </a>",
"    ]. A total of 106 neoplasms were diagnosed, of which VCE missed 20 (false negative rate 19 percent). However, this was lower than the miss rate for the standard diagnostic workup method (63 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The main disadvantage of wireless video capsule endoscopy is that it does not permit tissue sampling. It should generally not be performed in patients in whom small bowel obstruction is suspected since the capsule may become lodged proximal to the obstruction and may require laparotomy for retrieval.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Enteroscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteroscopy refers to the passage of a colonoscope or special enteroscope beyond the ligament of Treitz using push, intraoperative, or double-balloon enteroscopy techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/33\">",
"     33",
"    </a>",
"    ]. The main advantage compared to wireless video capsule endoscopy (VCE) is the ability to obtain tissue samples and perform therapeutic interventions.",
"   </p>",
"   <p>",
"    Enteroscopy can be complementary to VCE by allowing for tissue sampling of lesions identified during VCE. However, the procedure is invasive, can be technically challenging (and hence not always successful in visualizing the entire small bowel), and the required expertise and equipment are not always available. These techniques are all described in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/39/31352?source=see_link\">",
"     \"Evaluation of obscure gastrointestinal bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/4/24649?source=see_link\">",
"     \"Overview of deep small bowel enteroscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Other methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of novel endoscopic methods to visualize the small bowel are in various stages of development or are available on a limited basis. These include a single-balloon enteroscope (Olympus Optical Co, Ltd, Tokyo) and the Spirus Discovery SB system (Spirus Medical Inc, Stoughton, MA). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/39/31352?source=see_link\">",
"     \"Evaluation of obscure gastrointestinal bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of tumor markers in the evaluation of a suspected small bowel tumor is unclear. The majority of small bowel adenocarcinomas are positive for carcinoembryonic antigen (CEA) by immunohistochemistry [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/34,35\">",
"     34,35",
"    </a>",
"    ], and serum CEA was elevated in 44 percent of patients with metastatic or locally advanced small bowel adenocarcinoma in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/36\">",
"     36",
"    </a>",
"    ]. However, CEA is neither sufficiently sensitive nor specific to be used for diagnostic purposes.",
"   </p>",
"   <p>",
"    Measurement of urinary 5-hydroxyindoleacetic acid (5-HIAA) or serum chromogranin A (CGA) should not be routine but instead, done only if there is a strong clinical suspicion of carcinoid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnostic testing for carcinoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with small bowel carcinoid tumors (well-differentiated neuroendocrine tumors) often present with symptoms similar to those of other small bowel tumors. However, they may also become symptomatic from hormones secreted by the tumor cells. More than 90 percent of patients with the carcinoid syndrome have metastatic disease, typically to the liver. The presence of carcinoid syndrome is usually suspected because of otherwise unexplained diarrhea or flushing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/31/18938?source=see_link&amp;anchor=H17#H17\">",
"     \"Epidemiology, clinical features, and types of small bowel neoplasms\", section on 'Carcinoid tumors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=see_link\">",
"     \"Diagnosis of the carcinoid syndrome and tumor localization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link\">",
"     \"Clinical features of the carcinoid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Urinary excretion of 5-HIAA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A useful initial diagnostic test in patients with suspected carcinoid syndrome from a small bowel carcinoid is to measure 24-hour urinary excretion of 5-HIAA, which is the end product of serotonin metabolism. This test has a reported sensitivity of 75 percent and specificity of up to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/37\">",
"     37",
"    </a>",
"    ], but is fraught with errors that may be induced by the ingestion of certain drugs and foods (",
"    <a class=\"graphic graphic_table graphicRef79968 \" href=\"UTD.htm?7/54/8043\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Most patients with the carcinoid syndrome have urinary 5-HIAA excretion above 100",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    (523",
"    <span class=\"nowrap\">",
"     micromol/day).",
"    </span>",
"    There is a good correlation between tumor mass and urinary 5-HIAA levels; the sensitivity of urinary 5-HIAA is diminished in patients with nonmetastatic or asymptomatic carcinoid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis of the carcinoid syndrome and tumor localization\", section on 'Urinary excretion of 5-HIAA'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other biochemical tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other potentially useful initial diagnostic tests are serum chromogranin A (CGA) and serum 5-hydroxytryptamine (5-HT, serotonin). CGA is more sensitive than 24-hour urine 5-HIAA but less specific [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/39\">",
"     39",
"    </a>",
"    ]. Elevated CGA levels are present in a number of other conditions (",
"    <a class=\"graphic graphic_table graphicRef73287 \" href=\"UTD.htm?40/9/41116\">",
"     table 3",
"    </a>",
"    ), and specificity depends on the cutoff value. Serum CGA levels above 32",
"    <span class=\"nowrap\">",
"     unit/L",
"    </span>",
"    have a 75 percent sensitivity and 84 percent specificity for the detection of neuroendocrine tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=see_link&amp;anchor=H4#H4\">",
"     \"Diagnosis of the carcinoid syndrome and tumor localization\", section on 'Chromogranin concentration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Tumor localization by octreotide and MIBG scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radionuclide imaging using somatostatin receptor scintigraphy with indium-111",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    (Octreoscan&reg;) is a useful technique for localization of carcinoids because the tumor cells almost always contain somatostatin receptors, a property shared with other neuroendocrine neoplasms, some lymphomas (particularly extragastric marginal zone lymphomas [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/41\">",
"     41",
"    </a>",
"    ]) and small cell lung cancers. Somatostatin receptor scintigraphy has a greater than 90 percent sensitivity for identifying a carcinoid tumor in patients with carcinoid syndrome and it is superior to radionuclide imaging using radiolabeled (iodine-131 or 121) metaiodobenzylguanidine (MIBG) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Radiolabeled MIBG, which is taken up by the tumor and stored in its neurosecretory granules, can identify primary or metastatic carcinoid tumors only approximately 50 to 60 percent of the time [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tumor localization in patients with a small bowel neuroendocrine tumor is addressed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis of the carcinoid syndrome and tumor localization\", section on 'Tumor localization and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Surgical exploration",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, despite a thorough history, physical examination, and complete diagnostic workup, the correct diagnosis of small bowel malignancy was established preoperatively in only 70 percent of cases, with the remainder diagnosed at laparotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/46\">",
"     46",
"    </a>",
"    ]. However, improvements in cross-sectional imaging and the development of techniques such as wireless video capsule endoscopy have reduced the need for diagnostic laparotomy. In many situations, pathologic confirmation by biopsy is not needed prior to surgical exploration for resection in patients with a characteristic mass on CT or endoscopy.",
"   </p>",
"   <p>",
"    Nevertheless, exploratory laparotomy is the most sensitive diagnostic modality in evaluating a patient with a high suspicion of having a small bowel neoplasm. Exploration should be considered for a patient with occult GI bleeding, unexplained weight loss, or vague abdominal pain and an otherwise unrevealing diagnostic evaluation. Laparoscopy may also be useful for establishing the diagnosis of malignancy when the workup is otherwise negative and for obtaining adequate tissue samples if a diagnosis of lymphoma is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staging systems differ according to the primary histology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Adenocarcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly used staging system for small bowel adenocarcinomas is the TNM system of the combined AJCC (American Joint Committee on",
"    <span class=\"nowrap\">",
"     Cancer)/UICC",
"    </span>",
"    (International Union Against Cancer); the most recent 2010 edition is presented in the table (",
"    <a class=\"graphic graphic_table graphicRef59827 \" href=\"UTD.htm?7/30/7661\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/47\">",
"     47",
"    </a>",
"    ]. This schema does not apply to carcinoid tumors, lymphomas, or sarcomas; separate TNM staging criteria are available for carcinoid tumors and GIST tumors (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Ann Arbor staging system developed in 1971 for Hodgkin's disease (HD) was adapted for staging non-Hodgkin's lymphomas (NHLs). This staging system focuses on the number of tumor sites (nodal and extranodal), location, and the presence or absence of systemic (\"B\") symptoms (",
"    <a class=\"graphic graphic_table graphicRef73699 \" href=\"UTD.htm?36/59/37819\">",
"     table 5",
"    </a>",
"    ). The staging system used for lymphoma and the",
"    <span class=\"nowrap\">",
"     diagnostic/staging",
"    </span>",
"    tests that are recommended for the evaluation of a patient with a non-Hodgkin lymphoma are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/18/15658?source=see_link\">",
"     \"Initial evaluation and staging of non-Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sarcoma and carcinoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visceral leiomyosarcomas are sometimes staged according to the TNM system for soft tissue sarcomas (",
"    <a class=\"graphic graphic_table graphicRef66617 \" href=\"UTD.htm?23/13/23773\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/48\">",
"     48",
"    </a>",
"    ]. Separate TNM staging systems were introduced for small intestine stromal tumors (GISTs, (",
"    <a class=\"graphic graphic_table graphicRef51606 \" href=\"UTD.htm?8/35/8766\">",
"     table 7",
"    </a>",
"    )) and carcinoids (",
"    <a class=\"graphic graphic_table graphicRef58532 \" href=\"UTD.htm?41/15/42236\">",
"     table 8",
"    </a>",
"    ) with the 2010 edition of the TNM staging system [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/47,49\">",
"     47,49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and surveillance of non-metastatic carcinoid tumors\", section on 'Small intestine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     HISTOLOGY AND DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Differentiating the various small bowel tumors on light microscopy is generally straightforward, and the results of immunohistochemical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cytometric studies are usually confirmatory:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The morphologic appearance of GISTs can be predominantly spindle cell or epithelioid, and these tumors have a characteristic molecular signature. Over 80 percent of GISTs express the CD117 antigen, in contrast to leiomyomas and other spindle-cell tumors of the gastrointestinal (GI) tract (eg, leiomyosarcomas), which are typically CD117-negative.",
"      <br/>",
"      <br/>",
"      The CD117 antigen, which can be identified by immunohistochemical staining (IHC), is part of the KIT transmembrane receptor tyrosine kinase, a product of the c-kit (also denoted as KIT) protooncogene. In more than 80 percent of GIST cases, a mutation in the KIT gene leads to a structural variant of the KIT protein which is abnormally activated and enables oncogenic signaling in the cell.",
"      <br/>",
"      <br/>",
"      A subset of KIT-negative GISTs have activating mutations in a different receptor tyrosine kinase, platelet-derived growth factor receptor-alpha, which can only be identified using molecular techniques. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link&amp;anchor=H8#H8\">",
"       \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\", section on 'Histopathology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neuroendocrine differentiation, as is characteristic of a carcinoid or noncarcinoid neuroendocrine tumor, can be demonstrated by IHC staining for synaptophysin or chromogranin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6794?source=see_link&amp;anchor=H799304#H799304\">",
"       \"Pathology, classification, and grading of neuroendocrine tumors arising in the digestive system\", section on 'Morphology and immunohistochemistry'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41174?source=see_link&amp;anchor=H2#H2\">",
"       \"Neuroendocrine cancer of unknown primary site\", section on 'Pathologic classification'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IHC or cytometric studies for cell surface antigens typically identify lymphomas as being of either B-cell or T-cell origin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"       \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Differentiating an adenocarcinoma of the small bowel from other bowel adenocarcinomas (particularly in the setting of a locally advanced lesion) can be challenging. In contrast to colorectal cancers, which are almost always cytokeratin (CK) 20 positive and CK 7 negative, adenocarcinomas of the small bowel are less often CK 20 positive (47 to 67 percent) and more often CK7 positive (34 to 100 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10937/abstract/50,51\">",
"       50,51",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link\">",
"       \"Pathology and prognostic determinants of colorectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A variety of tumors, both malignant and benign, may arise within the small intestine. Malignant tumors include adenocarcinomas, carcinoids, stromal tumors (gastrointestinal stromal tumors [GISTs] and non-GIST soft tissue sarcomas), and lymphomas. Benign lesions that may arise in the small bowel include adenomas, leiomyomas, fibromas, and lipomas.",
"     </li>",
"     <li>",
"      The diagnosis of a small bowel tumor is often made late in the course of the disease, because these are generally rare conditions, and the symptoms are nonspecific (abdominal pain, weight loss, nausea and vomiting, occult GI tract bleeding). Early diagnosis requires a high index of suspicion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/31/18938?source=see_link&amp;anchor=H11#H11\">",
"       \"Epidemiology, clinical features, and types of small bowel neoplasms\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is no single best method for imaging the small intestine in a patient with a suspected small bowel tumor. The choices are radiographic (CT scan, small bowel series, enteroclysis) or endoscopic (upper endoscopy, wireless video capsule endoscopy, push enteroscopy, double-balloon endoscopy). The best testing strategy and sequence of diagnostic tests are not established, and there is debate as to how much diagnostic workup is adequate to exclude a small bowel tumor. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/39/31352?source=see_link\">",
"       \"Evaluation of obscure gastrointestinal bleeding\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      PET scanning with the radiotracer 18-F-deoxyglucose (FDG), particularly integrated",
"      <span class=\"nowrap\">",
"       PET/CT,",
"      </span>",
"      may be useful for initial diagnosis of small bowel neoplasms, staging, evaluating response to treatment, and restaging at the time of suspected disease recurrence; utility varies according to histology. (See",
"      <a class=\"local\" href=\"#H7028823\">",
"       'PET and integrated PET/CT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no tumor markers that are sufficiently sensitive or specific for the diagnosis of any small bowel tumor. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Tumor markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of carcinoid syndrome should be considered when the patient has suggestive symptoms such as otherwise unexplained diarrhea or flushing. In such cases, additional diagnostic testing may include biochemical tests of urine",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      serum to detect elevated levels of bioactive amines and other substances such as chromogranin A and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"       Octreotide",
"      </a>",
"      scanning. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link\">",
"       \"Clinical features of the carcinoid syndrome\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnostic testing for carcinoid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Staging systems differ according to the primary histology. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Staging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/1\">",
"      Ciresi DL, Scholten DJ. The continuing clinical dilemma of primary tumors of the small intestine. Am Surg 1995; 61:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/2\">",
"      Maglinte DD, O'Connor K, Bessette J, et al. The role of the physician in the late diagnosis of primary malignant tumors of the small intestine. Am J Gastroenterol 1991; 86:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/3\">",
"      Cunningham JD, Aleali R, Aleali M, et al. Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg 1997; 225:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/4\">",
"      North JH, Pack MS. Malignant tumors of the small intestine: a review of 144 cases. Am Surg 2000; 66:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/5\">",
"      Van Weyenberg SJ, Meijerink MR, Jacobs MA, et al. MR enteroclysis in the diagnosis of small-bowel neoplasms. Radiology 2010; 254:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/6\">",
"      Boudiaf M, Jaff A, Soyer P, et al. Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 2004; 233:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/7\">",
"      Bessette JR, Maglinte DD, Kelvin FM, Chernish SM. Primary malignant tumors in the small bowel: a comparison of the small-bowel enema and conventional follow-through examination. AJR Am J Roentgenol 1989; 153:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/8\">",
"      Bruneton JN, Drouillard J, Bourry J, et al. [Adenocarcinoma of the small intestine. Current state of diagnosis and treatment. A study of 27 cases and a review of the literature]. J Radiol 1983; 64:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/9\">",
"      Vuori JV. Primary malignant tumours of the small intestine. Analysis of cases diagnosed in Finland, 1953-1962. Acta Chir Scand 1971; 137:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/10\">",
"      Minardi AJ Jr, Zibari GB, Aultman DF, et al. Small-bowel tumors. J Am Coll Surg 1998; 186:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/11\">",
"      Laurent F, Raynaud M, Biset JM, et al. Diagnosis and categorization of small bowel neoplasms: role of computed tomography. Gastrointest Radiol 1991; 16:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/12\">",
"      Horton KM, Fishman EK. Multidetector-row computed tomography and 3-dimensional computed tomography imaging of small bowel neoplasms: current concept in diagnosis. J Comput Assist Tomogr 2004; 28:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/13\">",
"      Levy AD, Remotti HE, Thompson WM, et al. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 2003; 23:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/14\">",
"      HUDSON HL, MARGULIS AR. THE ROENTGEN FINDINGS OF CARCINOID TUMORS OF THE GASTROINTESTINAL TRACT: A REPORT OF 12 RECENT CASES. Am J Roentgenol Radium Ther Nucl Med 1964; 91:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/15\">",
"      Dudiak KM, Johnson CD, Stephens DH. Primary tumors of the small intestine: CT evaluation. AJR Am J Roentgenol 1989; 152:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/16\">",
"      Cockey BM, Fishman EK, Jones B, Siegelman SS. Computed tomography of abdominal carcinoid tumor. J Comput Assist Tomogr 1985; 9:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/17\">",
"      Chambers AJ, Pasieka JL, Dixon E, Rorstad O. Role of imaging in the preoperative staging of small bowel neuroendocrine tumors. J Am Coll Surg 2010; 211:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/18\">",
"      Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 2006; 11:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/19\">",
"      Bender GN, Maglinte DD, Kl&ouml;ppel VR, Timmons JH. CT enteroclysis: a superfluous diagnostic procedure or valuable when investigating small-bowel disease? AJR Am J Roentgenol 1999; 172:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/20\">",
"      Orjollet-Lecoanet C, M&eacute;nard Y, Martins A, et al. [CT enteroclysis for detection of small bowel tumors]. J Radiol 2000; 81:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/21\">",
"      Bender GN, Timmons JH, Williard WC, Carter J. Computed tomographic enteroclysis: one methodology. Invest Radiol 1996; 31:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/22\">",
"      Maglinte DD, Bender GN, Heitkamp DE, et al. Multidetector-row helical CT enteroclysis. Radiol Clin North Am 2003; 41:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/23\">",
"      Pilleul F, Penigaud M, Milot L, et al. Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 2006; 241:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/24\">",
"      Schmidt S, Lepori D, Meuwly JY, et al. Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of \"sign-by-sign\" correlation. Eur Radiol 2003; 13:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/25\">",
"      Paulsen SR, Huprich JE, Fletcher JG, et al. CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics 2006; 26:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/26\">",
"      Masselli G, Polettini E, Casciani E, et al. Small-bowel neoplasms: prospective evaluation of MR enteroclysis. Radiology 2009; 251:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/27\">",
"      Cronin CG, Scott J, Kambadakone A, et al. Utility of positron emission tomography/CT in the evaluation of small bowel pathology. Br J Radiol 2012; 85:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/28\">",
"      Watanabe N, Hayashi S, Kato H, et al. FDG-PET imaging in duodenal cancer. Ann Nucl Med 2004; 18:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/29\">",
"      Sperti C, Pasquali C, Fiore V, et al. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms. Am J Surg 2006; 191:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/30\">",
"      Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/31\">",
"      Cobrin GM, Pittman RH, Lewis BS. Increased diagnostic yield of small bowel tumors with capsule endoscopy. Cancer 2006; 107:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/32\">",
"      Lewis BS, Eisen GM, Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 2005; 37:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/33\">",
"      Fry LC, Bellutti M, Neumann H, et al. Incidence of bleeding lesions within reach of conventional upper and lower endoscopes in patients undergoing double-balloon enteroscopy for obscure gastrointestinal bleeding. Aliment Pharmacol Ther 2009; 29:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/34\">",
"      Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg 2002; 137:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/35\">",
"      Zhu L, Kim K, Domenico DR, et al. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA. J Surg Oncol 1996; 61:100.",
"     </a>",
"    </li>",
"    <li>",
"     Overman MJ, Morris J, Adinin R, et al. A phase II study of capecitabine and oxaliplatin (CAPOX) in metastatic adenocarcinoma of the small bowel or ampulla of Vater (abstract). Data presented at the ASCO Annual Gastrointestinal Cancers Symposium, Orlando, Florida, January 20, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/37\">",
"      Feldman JM. Urinary serotonin in the diagnosis of carcinoid tumors. Clin Chem 1986; 32:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/38\">",
"      Kema IP, de Vries EG, Slooff MJ, et al. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors. Clin Chem 1994; 40:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/39\">",
"      Modlin IM, Gustafsson BI, Moss SF, et al. Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol 2010; 17:2427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/40\">",
"      Campana D, Nori F, Piscitelli L, et al. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol 2007; 25:1967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/41\">",
"      Raderer M, Traub T, Formanek M, et al. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type. Br J Cancer 2001; 85:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/42\">",
"      Kvols LK, Brown ML, O'Connor MK, et al. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology 1993; 187:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/43\">",
"      Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990; 323:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/44\">",
"      Hanson MW, Feldman JM, Blinder RA, et al. Carcinoid tumors: iodine-131 MIBG scintigraphy. Radiology 1989; 172:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/45\">",
"      Bomanji J, Mather S, Moyes J, et al. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors. J Nucl Med 1992; 33:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/46\">",
"      Dabaja BS, Suki D, Pro B, et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004; 101:518.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th ed, Edge, SB, Byrd, DR, Compton, CC, et al (Eds), Springer, New York 2010. p.181.",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.285.",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.175.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/50\">",
"      Lee MJ, Lee HS, Kim WH, et al. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003; 16:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10937/abstract/51\">",
"      Chen ZM, Wang HL. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol 2004; 28:1352.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2516 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-A6750C7309-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10937=[""].join("\n");
var outline_f10_43_10937=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Radiographic imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - UGI/SBFT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - CT scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Angiography and radionuclide scanning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Enteroclysis and enterography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H24724378\">",
"      CT enterography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H24724393\">",
"      MR enterography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7028823\">",
"      - PET and integrated PET/CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1418955691\">",
"      Adenocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1418955698\">",
"      Lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1418955706\">",
"      Sarcoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1418955714\">",
"      Carcinoid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Endoscopic techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Upper endoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Wireless video capsule endoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Enteroscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Other methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Tumor markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnostic testing for carcinoid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Urinary excretion of 5-HIAA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other biochemical tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Tumor localization by octreotide and MIBG scans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Surgical exploration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Adenocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sarcoma and carcinoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      HISTOLOGY AND DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2516\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2516|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/0/33794\" title=\"diagnostic image 1\">",
"      CT scan jejunal adenoCA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/57/43921\" title=\"diagnostic image 2\">",
"      Malignant carcinoid ileum CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2516|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/39/7804\" title=\"table 1\">",
"      Dx tests small bowel tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/54/8043\" title=\"table 2\">",
"      Interference with 5 HIAA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/9/41116\" title=\"table 3\">",
"      Conditions associated with elevated chromogranin A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/30/7661\" title=\"table 4\">",
"      TNM small bowel cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/59/37819\" title=\"table 5\">",
"      Ann Arbor system in lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/13/23773\" title=\"table 6\">",
"      2010 TNM staging STS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/35/8766\" title=\"table 7\">",
"      TNM staging GIST",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/15/42236\" title=\"table 8\">",
"      TNM gastrointest carcinoid",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/34/33321?source=related_link\">",
"      Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=related_link\">",
"      Clinical presentation and diagnosis of primary gastrointestinal lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=related_link\">",
"      Diagnosis of the carcinoid syndrome and tumor localization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=related_link\">",
"      Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/31/18938?source=related_link\">",
"      Epidemiology, clinical features, and types of small bowel neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/39/31352?source=related_link\">",
"      Evaluation of obscure gastrointestinal bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/18/15658?source=related_link\">",
"      Initial evaluation and staging of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/32/6665?source=related_link\">",
"      Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41174?source=related_link\">",
"      Neuroendocrine cancer of unknown primary site",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/4/24649?source=related_link\">",
"      Overview of deep small bowel enteroscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=related_link\">",
"      Pathology and prognostic determinants of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6794?source=related_link\">",
"      Pathology, classification, and grading of neuroendocrine tumors arising in the digestive system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=related_link\">",
"      Treatment and surveillance of non-metastatic carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/8/21642?source=related_link\">",
"      Treatment of small bowel neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/58/34730?source=related_link\">",
"      Tyrosine kinase inhibitor therapy for advanced gastrointestinal stromal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17178?source=related_link\">",
"      Wireless video capsule endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_43_10938="Introducing solid foods and vitamin and mineral supplementation during infancy";
var content_f10_43_10938=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Introducing solid foods and vitamin and mineral supplementation during infancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10938/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10938/contributors\">",
"     Teresa K Duryea, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10938/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10938/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10938/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/43/10938/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/43/10938/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/43/10938/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary objective of feeding during the first year is the acquisition of nutrients for optimal growth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/1\">",
"     1",
"    </a>",
"    ]. The balance of energy intake to energy needs is of primary importance [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/2\">",
"     2",
"    </a>",
"    ]. Secondary goals include the acquisition of oromotor skills and appropriate eating behaviors.",
"   </p>",
"   <p>",
"    Feeding development is a \"learned progression of behaviors\" [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/1\">",
"     1",
"    </a>",
"    ]. It is dependent upon structural integrity and neurologic maturation and compounded by individual temperament, interpersonal relationships, environmental influences, and culture. Feeding practices during the first two years of life help to establish lifelong eating habits, so it is important to develop healthy eating habits [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The introduction of complementary foods (sometimes called beikost, or \"weaning foods\") and the need for vitamin and mineral supplementation during the first year of life will be discussed here. Breastfeeding and dietary recommendations for toddlers and preschool children and issues related to the introduction of solid foods in infants at high risk for allergy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link\">",
"     \"Infant benefits of breastfeeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42616?source=see_link\">",
"     \"Breastfeeding: Parental education and support\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=see_link\">",
"     \"Nutritional composition of human milk for full-term infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=see_link\">",
"     \"Dietary recommendations for toddlers, preschool, and school-age children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=see_link\">",
"     \"Introducing formula and solid foods to infants at risk for allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INFANT NUTRITIONAL REQUIREMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Energy requirements for infants vary depending upon age; approximate requirements are as follows (",
"    <a class=\"graphic graphic_figure graphicRef87702 \" href=\"UTD.htm?39/15/40190\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      0 to 2 months &ndash; 100 to 110",
"      <span class=\"nowrap\">",
"       kcal/kg",
"      </span>",
"      per day",
"     </li>",
"     <li>",
"      3 to 5 months &ndash; 85 to 95",
"      <span class=\"nowrap\">",
"       kcal/kg",
"      </span>",
"      per day",
"     </li>",
"     <li>",
"      6 to 8 months &ndash; 80 to 85",
"      <span class=\"nowrap\">",
"       kcal/kg",
"      </span>",
"      per day",
"     </li>",
"     <li>",
"      9 to 11 months &ndash; 80",
"      <span class=\"nowrap\">",
"       kcal/kg",
"      </span>",
"      per day",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Actual energy requirements for an infant vary depending on individual characteristics including medical needs and catch-up growth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/5\">",
"     5",
"    </a>",
"    ]. Energy requirements for breastfed infants are up to 15 percent less than for formula-fed infants.",
"   </p>",
"   <p>",
"    Energy intake is influenced by the number of eating occasions, number of foods consumed, energy density of foods consumed, and portion size [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/6\">",
"     6",
"    </a>",
"    ]. Infants have an innate ability to self-regulate energy intake (eg, larger-than-average portions are consumed with less frequent feedings; smaller-than-average portions are consumed if food is energy dense) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/6\">",
"     6",
"    </a>",
"    ]. However, innate self-regulation may be affected by factors that diminish hunger-driven eating behavior (eg, coercive feeding, restriction of intake, environmental cues) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Requirements for selected nutrients for infants are presented in the table (",
"    <a class=\"graphic graphic_table graphicRef62525 \" href=\"UTD.htm?3/6/3180\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HUMAN MILK AND INFANT FORMULA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human milk is the ideal food for full-term infants [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/8\">",
"     8",
"    </a>",
"    ]. Adequate intake of human milk or commercial infant formula meets the nutritional requirements for infants in the first six months of life. Thereafter, complementary foods help to supplement energy, iron, vitamins, and trace elements, and prepare the infant for a more diversified diet [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     COMPLEMENTARY FOODS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complementary foods (sometimes called beikost or \"weaning foods\") are solid foods and liquids other than human milk or infant formula that are eaten by infants as they make the transition from a liquid diet to a modified adult diet. By the end of the first year of life, most healthy infants obtain approximately one-half of their energy needs from complementary foods [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     WHEN TO INITIATE COMPLEMENTARY FOODS",
"    </span>",
"    &nbsp;&mdash;&nbsp;We agree with the American Academy of Pediatrics (AAP) recommendation that the introduction of complementary foods be delayed until the infant is at least four months old; exclusive breastfeeding is preferred until six months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/8\">",
"     8",
"    </a>",
"    ]. The World Health Organization and Canadian Paediatric Society recommend exclusive breastfeeding for the first six months of life [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The recommendation for exclusive breastfeeding for six months is supported by a systematic review of controlled trials and observational studies (from both developed and developing countries) demonstrating that infants who are exclusively breastfed for six months have growth that is comparable to that in infants who receive complementary foods beginning at four months, but have fewer gastrointestinal infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/11\">",
"     11",
"    </a>",
"    ]. In addition, in a randomized trial, hemoglobin, mean corpuscular volume, total iron-binding capacity, and red blood cell distribution width at six months of age were similar among infants who were exclusively breastfed for six months and those who initiated complementary foods at four months [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/12\">",
"     12",
"    </a>",
"    ]. Although serum ferritin was lower among exclusively breastfed infants (44 versus 70",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [44 versus 70",
"    <span class=\"nowrap\">",
"     mcg/L]),",
"    </span>",
"    it remained above the threshold for iron deficiency anemia (ie &ge;12",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [12",
"    <span class=\"nowrap\">",
"     mcg/L]).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link\">",
"     \"Infant benefits of breastfeeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link&amp;anchor=H16#H16\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) recommends that complementary foods be delayed until at least 17 weeks of age, but not beyond 26 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The European Food Safety Authority has concluded that for healthy full-term infants in the European Union, complementary foods may be safely introduced between four and six months [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Optimal timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;By four months of age, most infants have doubled their birth weight. Between four to six months of age, complementary foods become necessary to support growth, satisfy hunger, and supplement energy and nutrient needs [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/15\">",
"     15",
"    </a>",
"    ]. After six months of age, the volume of human milk ingested by exclusively breast-fed infants becomes insufficient to meet the infant's requirements for energy, protein, iron, zinc, and some fat-soluble vitamins [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Infant nutritional requirements'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Delay of introduction of complementary foods until at least four months of age may provide some benefit in reducing the risk of atopic dermatitis and atopic sensitization [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=see_link&amp;anchor=H12#H12\">",
"     \"Introducing formula and solid foods to infants at risk for allergic disease\", section on 'Introduction of solid foods to high risk infants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although age is generally a good predictor of readiness to eat solid foods, the use of age as the sole predictor may overlook the individual needs of the infant, particularly the infant who was born prematurely. In addition to age, the decision regarding the timing of introduction of solid foods should be based upon neurodevelopmental maturation and physiologic needs [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Developmental skills",
"    </span>",
"    &nbsp;&mdash;&nbsp;The introduction of solid foods should be delayed until the infant is able to sit with support and has good head and neck control [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"     18",
"    </a>",
"    ]. This developmental milestone can be easily and correctly determined by most mothers. Babies who can sit with support usually have achieved the other skills necessary to successfully eat solid foods:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adequate truncal control (indicated by the ability to push up from the prone position with straight elbows) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The ability to propel pur&eacute;ed foods to the posterior pharynx for swallowing.",
"     </li>",
"     <li>",
"      Extinction of the extrusion reflex (usually between four and five months of age). The extrusion reflex involves raising the tongue and pushing it against any object that is placed between child's lips [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/19\">",
"       19",
"      </a>",
"      ]. Persistence of the extrusion reflex makes spoon feeding difficult and frustrating for both the mother and the infant.",
"     </li>",
"     <li>",
"      Preparation for the varying textures of supplemental foods by putting their hands in their mouths, bringing their toys to their mouths, and exploring different ways of mouthing these objects [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The ability to indicate a desire for food (by opening the mouth and leaning forward) and satiety (by leaning back or turning away) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"       18",
"      </a>",
"      ]. This is usually achieved by five to six months of age.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional skills are necessary to eat lumpy foods and finger foods. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'How to advance'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Early introduction",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Lack of benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Introduction of complementary foods before four months of age has no known benefit. Parents often report that early introduction of cereal helps infants to sleep through the night, but evidence for this benefit is lacking. This issue was evaluated in a trial in which 106 infants were randomly assigned to receive a bedtime bottle containing rice cereal (1 tablespoon per ounce) at five weeks or four months [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/20\">",
"     20",
"    </a>",
"    ]. The addition of cereal was not associated with increased duration of sleep.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Potential harms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Introduction of complementary foods before four months of age is possibly harmful.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The introduction of solid foods before an infant has the oral motor skills to safely swallow them may result in aspiration [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Initiation of complementary foods before four to six months of age may result in inadequate or excess intake of energy or nutrients and increased renal solute load [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/22\">",
"       22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Early initiation of solid foods has been associated with an increased risk of obesity in some studies [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/23-27\">",
"       23-27",
"      </a>",
"      ], but not in all [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/28-30\">",
"       28-30",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H14#H14\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Metabolic programming'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Feeding cereals to infants at high risk for type 1 diabetes",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      celiac disease before three months of age may increase the risk of development of islet cell antibodies or celiac disease autoimmunity (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link&amp;anchor=H22#H22\">",
"       \"Pathogenesis of type 1 diabetes mellitus\", section on 'Cereals'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=see_link\">",
"       \"Clinical manifestations and diagnosis of celiac disease in children\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Potential harms of delayed introduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Withholding the introduction of complementary foods until after the infant is six months of age also may be associated with adverse effects, including [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/31-36\">",
"     31-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Decreased growth because of inadequate energy intake",
"     </li>",
"     <li>",
"      Iron deficiency in the breast-fed infant",
"     </li>",
"     <li>",
"      Delayed oral motor function",
"     </li>",
"     <li>",
"      Aversion to solid food",
"     </li>",
"     <li>",
"      Development of atopic disease (asthma, allergic rhinitis, eczema)",
"     </li>",
"     <li>",
"      Celiac disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Delaying the introduction of cereals to infants at high risk for type 1 diabetes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    celiac disease until after seven months of age may increase the risk of development of islet cell antibodies or celiac disease autoimmunity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link\">",
"     \"Pathogenesis of type 1 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=see_link\">",
"     \"Clinical manifestations and diagnosis of celiac disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     WHAT TO FEED AND HOW TO ADVANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The types of supplemental food presented to young children are influenced by culture, tradition, and individual preference [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/1,13,37\">",
"     1,13,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The infant's growth should be monitored at each health-care visit to detect and address slow growth or other nutritional problems [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=see_link\">",
"     \"Clinical evaluation of the obese child and adolescent\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=see_link&amp;anchor=H13#H13\">",
"     \"Normal growth patterns in infants and prepubertal children\", section on 'Evaluation of growth'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link&amp;anchor=H2#H2\">",
"     \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Measurement of growth'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The guidelines below are based upon the recommendations of the American Academy of Pediatrics (AAP) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committees on Nutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13,18\">",
"     13,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     What to feed",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complementary foods should be used in conjunction with human milk or commercial infant formula to provide the full range of nutrients needed for infant growth, development, and health (",
"    <a class=\"graphic graphic_table graphicRef62525 \" href=\"UTD.htm?3/6/3180\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"     18",
"    </a>",
"    ]. As solid foods are introduced, infants should consume no more than 28 to 32 ounces of formula or human milk per day (",
"    <a class=\"graphic graphic_table graphicRef70327 \" href=\"UTD.htm?29/37/30301\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Infant nutritional requirements'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Single-ingredient foods should be introduced first [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"       18",
"      </a>",
"      ]. The AAP Committee on Nutrition suggests that infant cereals and pur&eacute;ed meats be offered first because they provide iron and zinc, which are the nutrients most likely deficient in the diets of infants in the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18,38,39\">",
"       18,38,39",
"      </a>",
"      ]. Pur&eacute;ed meats increase the absorption of nonheme iron [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/40\">",
"       40",
"      </a>",
"      ]. Once these foods are accepted, strained or pur&eacute;ed fruits and vegetables may be added. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Cereals'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H15\">",
"       'Pur&eacute;ed foods'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      At least one feeding per day should contain foods rich in vitamin C to promote iron absorption. The absorption of iron is similar from meals that contain apple or orange juice [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/41\">",
"       41",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Fruit juice'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Fat and cholesterol intake are not restricted in infants. The ESPGHAN Committee on Nutrition recommends that fat constitute at least 25 percent of energy intake in infants [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The addition of sugar and salt is discouraged [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/42\">",
"       42",
"      </a>",
"      ]. Adding sugar and salt do not increase the acceptability of foods by the infant. Avoiding added sugar and salt during infancy may help to set a lower threshold for sweet and salty tastes later in life [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13,43,44\">",
"       13,43,44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Overconsumption of energy-dense complementary foods may induce excessive weight gain in infancy, which may have long-term implications [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/45-47\">",
"       45-47",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H14#H14\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Metabolic programming'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Cereals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single-grain infant cereals are good choices for the first supplemental food because they supply additional energy and iron [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/48\">",
"     48",
"    </a>",
"    ]. Rice cereal traditionally is offered first because it is the least allergenic and is easily accessible. The introduction of wheat cereal should not be delayed beyond six months of age. Evidence that such a delay protects against the development of wheat allergy is lacking. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=see_link&amp;anchor=H12#H12\">",
"     \"Introducing formula and solid foods to infants at risk for allergic disease\", section on 'Introduction of solid foods to high risk infants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infant cereals can be prepared by adding human milk, infant formula, or water. Cereal should be offered initially in small amounts (1 teaspoon) at the end of breast- or bottle-feeding. The amount of cereal should be gradually increased to approximately one-half cup per day (",
"    <a class=\"graphic graphic_table graphicRef70327 \" href=\"UTD.htm?29/37/30301\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cereal should be fed with a spoon. Spoon feeding enhances oral motor function, which may influence speech development.",
"   </p>",
"   <p>",
"    Cereal should not be added to bottles, except if medically indicated for gastroesophageal reflux (GER). Adding cereal to bottles delays the opportunity to learn to eat from a spoon. In addition, adding cereal to the bottle may contribute to the development of obesity by increasing the caloric density of formula or by confusing the body's signals for satiety and thirst. Once they are developmentally ready for solid foods, infants with GER should receive cereal from a spoon in addition to the cereal in the bottle. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=see_link\">",
"     \"Gastroesophageal reflux in infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23657?source=see_link\">",
"     \"Gastroesophageal reflux in premature infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Pur&eacute;ed foods",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of pur&eacute;ed foods should gradually be added to provide diverse and balanced \"meals\". Single-ingredient pur&eacute;es are recommended initially. The AAP Committee on Nutrition suggests that infant cereals and pur&eacute;ed meats be offered before pur&eacute;ed or strained fruits and vegetables [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"     18",
"    </a>",
"    ]. Advancing the complexity and texture of pur&eacute;ed foods is discussed below. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Pur&eacute;es'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Home-prepared pur&eacute;ed foods &ndash; Parents may choose to prepare pur&eacute;ed foods at home for a variety of reasons (eg, freshness, increased variety and texture, cost, avoidance of preservatives, etc). The United States Department of Agriculture provides guidelines for safe preparation of baby food at home (",
"    <a class=\"external\" href=\"file://www.fns.usda.gov/tn/Resources/feedinginfants-ch12.pdf\">",
"     www.fns.usda.gov/tn/Resources/feedinginfants-ch12.pdf",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If pur&eacute;ed foods are prepared at home, it is important to ensure that the energy and nutrient content is adequate (",
"    <a class=\"graphic graphic_table graphicRef62525 \" href=\"UTD.htm?3/6/3180\">",
"     table 1",
"    </a>",
"    ). In observational studies, many home-prepared foods were low in certain nutrients (energy, fat, protein, iron, and zinc) and the nutrient content of home-prepared foods was more variable than that of foods prepared commercially [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Infant nutritional requirements'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Home-prepared spinach, beets, green beans, squash, and carrots should not be given to infants younger than four months of age. These foods may contain sufficient nitrate to cause methemoglobinemia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link\">",
"     \"Genetics and pathogenesis of methemoglobinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Parents should read food labels for sodium content and buy \"no added salt\" products. Canned foods should not be used for the home preparation of pur&eacute;ed infant foods if they contain large amounts of added salt and sugar. The dietary reference intake for sodium is 120",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for infants 0 to 6 months of age and 370",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for infants 7 to 12 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Storage of pur&eacute;ed foods &ndash; Care must be taken to avoid spoilage of pur&eacute;ed foods. Jars of infant foods, once opened, may be refrigerated for a maximum of 48 hours before being discarded. Commercial foods should be served from a bowl rather than out of the jar; food left in the bowl should be discarded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Fruit juice",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fruit juices may be introduced when the infant can drink from a cup (beginning at approximately six months of age). Before the infant reaches six months of age, fruit juice provides no nutritional benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/2\">",
"     2",
"    </a>",
"    ]. However, 100 percent fruit juice (as opposed to \"fruit drinks\") can be part of a well-balanced diet for infants and children older than six months of age when consumed in",
"    <strong>",
"     limited",
"    </strong>",
"    quantities (ie, 4 to 6 ounces per day) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Juices containing vitamin C may improve the absorption of iron [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'What to feed'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Juices without",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/33/32275?source=see_link\">",
"     sorbitol",
"    </a>",
"    and with a low fructose:glucose ratio (eg, white grape juice) are better tolerated in some infants than are juices containing sorbitol (eg, prune juice) and juices with a fructose:glucose ratio greater than 2 (eg, apple or pear juice) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/59-62\">",
"     59-62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The AAP Committee on Nutrition makes the following recommendations regarding juice consumption in infants [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18,56\">",
"     18,56",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fruit juice should be offered only from a cup",
"     </li>",
"     <li>",
"      Consumption of fruit juice should not exceed 4 to 6 ounces per day",
"     </li>",
"     <li>",
"      Fruit juice should be used as part of a meal or a snack and not be sipped throughout the day; it should not be consumed at bedtime or in bed",
"     </li>",
"     <li>",
"      Excessive fruit juice consumption may be associated with malnutrition (overnutrition and undernutrition), diarrhea, flatulence, abdominal distention, and dental caries [",
"      <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/59,63-66\">",
"       59,63-66",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=see_link\">",
"       \"Clinical evaluation of the obese child and adolescent\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link&amp;anchor=H11#H11\">",
"       \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Etiology'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fruit juice consumed by infants and children should be pasteurized, because unpasteurized fruit juice may contain pathogens (eg,",
"      <em>",
"       Escherichia coli",
"      </em>",
"      O157:H7) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16426?source=see_link&amp;anchor=H11#H11\">",
"       \"Food poisoning in children\", section on 'Escherichia coli'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Calcium-fortified juices provide a bioavailable source of calcium but lack other nutrients present in human milk, infant formula, and cow's milk",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Cow's milk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AAP Committee on Nutrition recommends that the consumption of whole, unmodified cow's milk be avoided before the infant is one year of age because of the increased renal solute load and the increased risk of iron deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13,18,67-69\">",
"     13,18,67-69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ESPGHAN Committee on Nutrition suggests that cow's milk not be used as the main drink before 12 months of age; small volumes of cow's milk may be added to complementary foods [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Foods to avoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain foods should be avoided in infants younger than one year of age. They include hard, round foods (eg, nuts, grapes, raw carrots, and round candies), which can lead to choking [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], and honey (because of the association of honey with infant botulism) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link\">",
"     \"Botulism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, the AAP suggests that unmodified cow's milk be avoided in infants younger than 12 months of age. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Cow's milk'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Delaying the introduction of foods considered to be highly allergenic (eg, eggs, fish, peanuts, tree nuts) beyond the age of four to six months has been suggested as a way to prevent atopic disease in high-risk children (those with a first-degree relative with documented allergic disease). However, various professional groups, including the AAP Committee on Nutrition and Section on Allergy and Immunology and the ESPGHAN Committee on Nutrition, found no convincing evidence that this practice has a significant protective effect. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=see_link\">",
"     \"Introducing formula and solid foods to infants at risk for allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     How much to feed",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overfeeding may induce excessive weight gain in infancy, which may have long-term implications [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. Infants should be permitted to stop eating when they indicate that they are full (eg, by leaning back or turning away) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18,71-73\">",
"     18,71-73",
"    </a>",
"    ]. Attempts to get the infant to eat as much as possible at bedtime in hopes that he or she will sleep through the night should be discouraged [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/42\">",
"     42",
"    </a>",
"    ]. There is no evidence that this practice is effective [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/20\">",
"     20",
"    </a>",
"    ]. It may lead to overeating by overriding the infant's innate ability to regulate energy intake. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H14#H14\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Metabolic programming'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     How to advance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complexity and texture of complementary foods are advanced in parallel with the infant's development of feeding skills [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13,17\">",
"     13,17",
"    </a>",
"    ]. Combination foods may be offered to infants after they have demonstrated an ability to tolerate the individual components.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Pur&eacute;es",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single-ingredient foods should be introduced one at a time at intervals of three to five days to permit the identification of food intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"     18",
"    </a>",
"    ]. The AAP Committee on Nutrition suggests that infant cereals and pur&eacute;ed meats be offered initially; once these foods are accepted, strained or pur&eacute;ed fruits and vegetables can be added [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"     18",
"    </a>",
"    ]. The objectives are to introduce a variety of foods, tastes, and textures by the end of the first year and to ensure that the combination of human milk and complementary feedings meet the infant's nutritional requirements (",
"    <a class=\"graphic graphic_table graphicRef62525 \" href=\"UTD.htm?3/6/3180\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Infant nutritional requirements'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The acceptability of new foods increases with repeated exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/48,74-77\">",
"     48,74-77",
"    </a>",
"    ]. Up to 15 exposures may be necessary before a new food is accepted [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/77\">",
"     77",
"    </a>",
"    ]. Breastfeeding may facilitate the acceptance of solid foods as a result of the variety of flavors transmitted through human milk [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/74,75\">",
"     74,75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The first solid foods offered should be finely pur&eacute;ed, contain only one ingredient, and should not contain additives (salt, sugar). Combination foods (eg, fruit and cereal, meat and vegetable) may be given after the child tolerates the individual components.",
"   </p>",
"   <p>",
"    Once thin pur&eacute;es are tolerated and the infant can sit independently and tries to grasp food with his or her hands, thicker pur&eacute;es and soft mashed foods can be introduced [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/73\">",
"     73",
"    </a>",
"    ]. By around eight months of age, infants have usually mastered thick pur&eacute;es and have developed sufficient tongue flexibility to chew and swallow food with more texture (ground food, mashed foods with small, soft lumps) in larger portions (",
"    <a class=\"graphic graphic_table graphicRef70327 \" href=\"UTD.htm?29/37/30301\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13,73\">",
"     13,73",
"    </a>",
"    ]. Lumpier blends often contain pur&eacute;ed food with small pieces of pasta, vegetables, or meat. The incremental increase in varieties of textures is important to the acquisition of normal chewing and swallowing skills and to the acceptance of different textures [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Finger foods",
"    </span>",
"    &nbsp;&mdash;&nbsp;By 8 to 10 months of age, infants begin to refine the skills necessary to eat finger foods independently. These skills include the ability to sit independently; the eye-hand coordination needed to grasp, manipulate, and release food; the ability to \"chew\" (even in the absence of teeth); and to swallow. By the time the infant is 12 months of age, the hand grasp matures to a fine pincer grasp, improving the ability to eat finger foods.",
"   </p>",
"   <p>",
"    Finely chopped, soft foods (eg, small pieces of soft fruits, vegetables, cheese, well-cooked meats, cooked pasta, etc) and foods that dissolve easily (eg, baby crackers, dry cereal) can be offered as finger foods [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/73\">",
"     73",
"    </a>",
"    ]. Foods that are choking hazards should be avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18\">",
"     18",
"    </a>",
"    ]. These foods include hot dogs, nuts (particularly peanuts), grapes, raisins, raw carrots, popcorn, and round candies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Self-feeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;By 9 to 12 months of age, most infants have the manual dexterity to feed themselves, drink from a standard cup using two hands, and eat foods prepared for the rest of the family with minor adaptations (eg, cut into bite-sized portions). Nonetheless, a combination of independent and dependent feeding is necessary to satisfy the energy and nutrient needs of the child during this phase of improving self-feeding skills [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Infant nutritional requirements'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Feeding environment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of healthy eating habits requires a healthy feeding environment and a healthy feeding relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/73\">",
"     73",
"    </a>",
"    ]. In a healthy feeding relationship, the infant initiates and guides feeding interactions, and the caregiver must:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Respond early and appropriately to hunger and fullness cues",
"     </li>",
"     <li>",
"      Recognize the infant's developmental abilities and feeding skills",
"     </li>",
"     <li>",
"      Balance the infant's need for help with encouragement of self-feeding",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     MINERAL AND VITAMIN SUPPLEMENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Iron",
"    </span>",
"    &nbsp;&mdash;&nbsp;The minimum daily requirements for iron vary depending upon gestational age and birth weight as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/78\">",
"     78",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Full-term infant &ndash; 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"     </li>",
"     <li>",
"      Premature infant and low-birth-weight infants &ndash; 2 to 4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Breast-fed infants &ndash; After four months of age, the iron requirement of a full-term breast-fed infant may exceed the amount that can be provided by human milk alone. Some form of iron supplementation (eg, pur&eacute;ed meats, iron-fortified infant cereal, oral iron) is recommended to provide at least 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/13,78-80\">",
"     13,78-80",
"    </a>",
"    ]. An average of two servings (2 ounces of dry cereal per serving) of iron-fortified cereal or one-half to one jar of pur&eacute;ed meat per day is sufficient to meet the daily iron requirement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Formula-fed infants &ndash; Infants who receive iron-fortified formula (12 mg elemental iron per liter) do not need additional iron supplementation.",
"   </p>",
"   <p>",
"    Low-birth-weight and preterm infants &ndash; The iron stores of preterm infants often are depleted by two to three months of age. These infants should receive at least 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day of iron throughout the first year of life [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/78,81\">",
"     78,81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Fluoride",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoride supplementation begins when the child is six months of age, depending upon the fluoride concentration in the water source (for those using powdered or concentrated infant formula) (",
"    <a class=\"graphic graphic_table graphicRef69038 \" href=\"UTD.htm?30/16/30987\">",
"     table 3",
"    </a>",
"    ) and whether the infant is exposed to other sources of fluoride [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ready-to-feed infant formulas are produced with water that does not contain fluoride. Fluoride supplementation, beginning at six months of age, is warranted for infants who are fed ready-to-feed formula as the sole source of nutrient and fluid intake. Fluoride supplementation should begin at six months of age for exclusively breast-fed infants, as well.",
"   </p>",
"   <p>",
"    The effects of water filtration systems on the fluoride content of bottled water are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33192?source=see_link&amp;anchor=H13#H13\">",
"     \"Preventive dental care and counseling for infants and young children\", section on 'Fluoride'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D supplementation should be provided to exclusively breast-fed infants and non-breast-fed infants who do not ingest an adequate amount of vitamin D-fortified milk daily. The recommended daily intake and timing, duration, and dose of vitamin D supplementation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=see_link&amp;anchor=H723639#H723639\">",
"     \"Vitamin D insufficiency and deficiency in children and adolescents\", section on 'Vitamin D supplementation for infants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Vitamin B12",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adequate intake (AI, previously RDA) for vitamin B12 (cobalamin) is 0.4 mcg per day for infants between birth and six months of age and 0.5 mcg per day for infants between 7 and 12 months.",
"   </p>",
"   <p>",
"    Vitamin B12 (cobalamin) supplementation is recommended for breast-fed infants of strict vegetarian mothers [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/83\">",
"     83",
"    </a>",
"    ]. The adverse neurologic consequences of vitamin B12 deficiency may be devastating and irreversible. Physiologically active vitamin B12 is available from supplements and in some fortified cereals, soy beverages, and nutritional yeast. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link&amp;anchor=H2126391#H2126391\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link&amp;anchor=H19#H19\">",
"     \"Vegetarian diets for children\", section on 'Vitamin B12'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33098?source=see_link&amp;anchor=H24346287#H24346287\">",
"     \"Overview of acquired peripheral neuropathies in children\", section on 'Vitamin B12 (cobalamin) deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Fat-soluble vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supplementation with fat-soluble vitamins (vitamins A, D, E, and K) should be considered in infants who have chronic liver disease or fat malabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?10/43/10938/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/59/7091?source=see_link\">",
"       \"Patient information: Starting solid foods with babies (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/27/4531?source=see_link\">",
"       \"Patient information: Weaning from breastfeeding (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/32/41476?source=see_link\">",
"       \"Patient information: Starting solid foods during infancy (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/0/25602?source=see_link\">",
"       \"Patient information: Weaning from breastfeeding (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Energy requirements for infants vary between 80 and 110",
"      <span class=\"nowrap\">",
"       kcal/kg",
"      </span>",
"      per day, depending upon age. Infants have an innate ability to self-regulate energy intake that may be affected by factors that diminish hunger-driven eating behavior. Requirements for selected nutrients for infants are presented in the table (",
"      <a class=\"graphic graphic_table graphicRef62525 \" href=\"UTD.htm?3/6/3180\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Infant nutritional requirements'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adequate intake of human milk or commercial infant formula meets the nutritional requirements for infants in the first six months of life. By the end of the first year of life, most healthy infants obtain approximately one-half of their energy needs from complementary foods. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Human milk and infant formula'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Complementary foods'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that complementary foods be introduced between four and six months of age if the infant is able to sit with support and has good head and neck control (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'When to initiate complementary foods'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complementary foods should be used in combination with human milk or commercial infant formula to provide the full range of nutrients needed for infant growth, development, and health (",
"      <a class=\"graphic graphic_table graphicRef62525 \" href=\"UTD.htm?3/6/3180\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef70327 \" href=\"UTD.htm?29/37/30301\">",
"       table 2",
"      </a>",
"      ). Complementary foods should be offered using a spoon or infant feeder; they should not be added to a bottle.",
"     </li>",
"     <li>",
"      Single-ingredient foods should be introduced first. We suggest that infant cereals and pur&eacute;ed meats be offered initially (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Once these foods are accepted, pur&eacute;ed fruits and vegetables may be added. At least one feeding per day should contain foods rich in vitamin C. The addition of sugar and salt to complementary foods is discouraged. Honey and foods that may lead to choking should be avoided. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'What to feed'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that fruit juices not be offered to children before six months of age (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). During the first year of life, only 100 percent fruit juice should be consumed and fruit juice consumption should be limited to 4 to 6 ounces per day (",
"      <a class=\"graphic graphic_table graphicRef70327 \" href=\"UTD.htm?29/37/30301\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Fruit juice'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants should be permitted to stop eating when they indicate that they are full (eg, by leaning back or turning away). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'How much to feed'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The complexity and texture of complementary foods are advanced in parallel with the development of feeding skills. Combination foods can be given after the infant tolerates the individual components. The texture of foods is advanced initially from thin to thick pur&eacute;es. By approximately eight months of age, infants can usually chew and swallow more solid foods (eg, cooked pasta, vegetables). Between 8 and 10 months of age, infants usually can begin to eat finger foods. By 9 to 12 months of age, most infants can feed themselves, but they require a combination of dependent and independent feeding to satisfy energy and nutrient needs. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'How to advance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Breast-fed infants require some form of iron supplementation (iron-fortified infant cereal, pur&eacute;ed meats, elemental iron) after four to six months of age to meet their iron requirement (1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day). Infants who receive iron-fortified formula do not require additional iron supplementation. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Iron'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fluoride supplementation begins when the child is six months of age, depending upon the fluoride concentration in the water source (",
"      <a class=\"graphic graphic_table graphicRef69038 \" href=\"UTD.htm?30/16/30987\">",
"       table 3",
"      </a>",
"      ) and whether the infant is exposed to other sources of fluoride. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Fluoride'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/1\">",
"      Stevenson RD, Allaire JH. The development of normal feeding and swallowing. Pediatr Clin North Am 1991; 38:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/2\">",
"      Woodruff CW. The science of infant nutrition and the art of infant feeding. JAMA 1978; 240:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/3\">",
"      Stang J. Improving the eating patterns of infants and toddlers. J Am Diet Assoc 2006; 106:S7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/4\">",
"      Skinner JD, Carruth BR, Bounds W, et al. Do food-related experiences in the first 2 years of life predict dietary variety in school-aged children? J Nutr Educ Behav 2002; 34:310.",
"     </a>",
"    </li>",
"    <li>",
"     Food and Agriculture Organization of the United Nations (FAO), World Health Organization (WHO) and United Nations University (UNU): Human Energy Requirements. Chapter 2: Energy requirements of infants from birth to 12 months. Available at: file://www.fao.org/docrep/007/y5686e/y5686e05.htm (Accessed on January 21, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/6\">",
"      Fox MK, Devaney B, Reidy K, et al. Relationship between portion size and energy intake among infants and toddlers: evidence of self-regulation. J Am Diet Assoc 2006; 106:S77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/7\">",
"      Fomon SJ. Taste acquisition and appetite control. Pediatrics 2000; 106:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/8\">",
"      Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Complementary feeding. file://www.who.int/nutrition/topics/complementary_feeding/en/index.html (Accessed on April 19, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/10\">",
"      Boland M. Exclusive breastfeeding should continue to six months. Paediatr Child Health 2005; 10:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/11\">",
"      Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev 2012; 8:CD003517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/12\">",
"      Jonsdottir OH, Thorsdottir I, Hibberd PL, et al. Timing of the introduction of complementary foods in infancy: a randomized controlled trial. Pediatrics 2012; 130:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/13\">",
"      Agostoni C, Decsi T, Fewtrell M, et al. Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2008; 46:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/14\">",
"      European Food, Safety Authority. Scientific opinion on the appropriate age for introduction of complementary feeding of infants. EFSA Journal 2009; 7:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/15\">",
"      Evans Morris S. Eating readiness cues: Introducing supplemental foods. Pediatric Basics 1992; 61:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/16\">",
"      Zutavern A, Brockow I, Schaaf B, et al. Timing of solid food introduction in relation to atopic dermatitis and atopic sensitization: results from a prospective birth cohort study. Pediatrics 2006; 117:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/17\">",
"      Kleinman RE. Learning about dietary variety: The first steps. Pediatric Basics 1994; 68:2.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Complementary feeding. In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.113.",
"    </li>",
"    <li>",
"     Eiger MS. Feeding of infants and children. In: Primary Pediatric Care, 4th ed, Mosby, St. Louis 2001. p.184.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/20\">",
"      Macknin ML, Medendorp SV, Maier MC. Infant sleep and bedtime cereal. Am J Dis Child 1989; 143:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/21\">",
"      Hall RT, Carroll RE. Infant feeding. Pediatr Rev 2000; 21:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/22\">",
"      Fomon SJ. Potential renal solute load: considerations relating to complementary feedings of breastfed infants. Pediatrics 2000; 106:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/23\">",
"      Ong KK, Emmett PM, Noble S, et al. Dietary energy intake at the age of 4 months predicts postnatal weight gain and childhood body mass index. Pediatrics 2006; 117:e503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/24\">",
"      Wilson AC, Forsyth JS, Greene SA, et al. Relation of infant diet to childhood health: seven year follow up of cohort of children in Dundee infant feeding study. BMJ 1998; 316:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/25\">",
"      Huh SY, Rifas-Shiman SL, Taveras EM, et al. Timing of solid food introduction and risk of obesity in preschool-aged children. Pediatrics 2011; 127:e544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/26\">",
"      Hawkins SS, Cole TJ, Law C, Millennium Cohort Study Child Health Group. An ecological systems approach to examining risk factors for early childhood overweight: findings from the UK Millennium Cohort Study. J Epidemiol Community Health 2009; 63:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/27\">",
"      Weng SF, Redsell SA, Swift JA, et al. Systematic review and meta-analyses of risk factors for childhood overweight identifiable during infancy. Arch Dis Child 2012; 97:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/28\">",
"      Burdette HL, Whitaker RC, Hall WC, Daniels SR. Breastfeeding, introduction of complementary foods, and adiposity at 5 y of age. Am J Clin Nutr 2006; 83:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/29\">",
"      Yeung DL, Pennell MD, Leung M, Hall J. Infant fatness and feeding practices: a longitudinal assessment. J Am Diet Assoc 1981; 79:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/30\">",
"      Lin SL, Leung GM, Lam TH, Schooling CM. Timing of Solid Food Introduction and Obesity: Hong Kong's \"Children of 1997\" Birth Cohort. Pediatrics 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/31\">",
"      Guthie HA. Introduction of solid foods - Part 2. Consequences of early and late timing. In-Touch 1998; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/32\">",
"      Underwood BA, Hofvander Y. Appropriate timing for complementary feeding of the breast-fed infant. A review. Acta Paediatr Scand Suppl 1982; 294:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/33\">",
"      ILLINGWORTH RS, LISTER J. THE CRITICAL OR SENSITIVE PERIOD, WITH SPECIAL REFERENCE TO CERTAIN FEEDING PROBLEMS IN INFANTS AND CHILDREN. J Pediatr 1964; 65:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/34\">",
"      Northstone K, Emmett P, Nethersole F, ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. The effect of age of introduction to lumpy solids on foods eaten and reported feeding difficulties at 6 and 15 months. J Hum Nutr Diet 2001; 14:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/35\">",
"      Ivarsson A, Myl&eacute;us A, Norstr&ouml;m F, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics 2013; 131:e687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/36\">",
"      Nwaru BI, Takkinen HM, Niemel&auml; O, et al. Timing of infant feeding in relation to childhood asthma and allergic diseases. J Allergy Clin Immunol 2013; 131:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/37\">",
"      Mennella JA, Ziegler P, Briefel R, Novak T. Feeding Infants and Toddlers Study: the types of foods fed to Hispanic infants and toddlers. J Am Diet Assoc 2006; 106:S96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/38\">",
"      Krebs NF, Westcott JE, Butler N, et al. Meat as a first complementary food for breastfed infants: feasibility and impact on zinc intake and status. J Pediatr Gastroenterol Nutr 2006; 42:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/39\">",
"      Briefel R, Ziegler P, Novak T, Ponza M. Feeding Infants and Toddlers Study: characteristics and usual nutrient intake of Hispanic and non-Hispanic infants and toddlers. J Am Diet Assoc 2006; 106:S84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/40\">",
"      Engelmann MD, Davidsson L, Sandstr&ouml;m B, et al. The influence of meat on nonheme iron absorption in infants. Pediatr Res 1998; 43:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/41\">",
"      Shah M, Griffin IJ, Lifschitz CH, Abrams SA. Effect of orange and apple juices on iron absorption in children. Arch Pediatr Adolesc Med 2003; 157:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/42\">",
"      Fomon SJ, Filer LJ Jr, Anderson TA, Ziegler EE. Recommendations for feeding normal infants. Pediatrics 1979; 63:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/43\">",
"      Beauchamp GK, Moran M. Dietary experience and sweet taste preference in human infants. Appetite 1982; 3:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/44\">",
"      Fomon SJ, Ziegler EE, Nelson SE, Edwards BB. Sweetness of diet and food consumption by infants. Proc Soc Exp Biol Med 1983; 173:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/45\">",
"      Baird J, Fisher D, Lucas P, et al. Being big or growing fast: systematic review of size and growth in infancy and later obesity. BMJ 2005; 331:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/46\">",
"      Monteiro PO, Victora CG. Rapid growth in infancy and childhood and obesity in later life--a systematic review. Obes Rev 2005; 6:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/47\">",
"      Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr 2006; 95:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/48\">",
"      Ziegler P, Hanson C, Ponza M, et al. Feeding Infants and Toddlers Study: meal and snack intakes of Hispanic and non-Hispanic infants and toddlers. J Am Diet Assoc 2006; 106:S107.",
"     </a>",
"    </li>",
"    <li>",
"     United States Department of Agriculture. Chapter 12. Home-prepared baby food. In: Food and Nutriton Service. Feeding Infants: A Guide for Use in Child Nutrition Programs. July 2002. www.fns.usda.gov/tn/Resources/feedinginfants-ch12.pdf (Accessed on January 11, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/50\">",
"      Stordy BJ, Redfern AM, Morgan JB. Healthy eating for infants--mothers' actions. Acta Paediatr 1995; 84:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/51\">",
"      van den Boom S, Kimber AC, Morgan JB. Nutritional composition of home-prepared baby meals in Madrid. Comparison with commercial products in Spain and home-made meals in England. Acta Paediatr 1997; 86:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/52\">",
"      Mel&oslash; R, Gellein K, Evje L, Syversen T. Minerals and trace elements in commercial infant food. Food Chem Toxicol 2008; 46:3339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/53\">",
"      Savino F, Maccario S, Guidi C, et al. Methemoglobinemia caused by the ingestion of courgette soup given in order to resolve constipation in two formula-fed infants. Ann Nutr Metab 2006; 50:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/54\">",
"      Greer FR, Shannon M, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Committee on Environmental Health. Infant methemoglobinemia: the role of dietary nitrate in food and water. Pediatrics 2005; 116:784.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Appendix J. Dietary Reference Intakes: Recommended Intakes for Individuals, Food and Nutrition Board, Institute of Medicine. In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.1293.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/56\">",
"      Committee on Nutrition. American Academy of Pediatrics: The use and misuse of fruit juice in pediatrics. Pediatrics 2001; 107:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/57\">",
"      Fairweather-Tait S, Fox T, Wharf SG, Eagles J. The bioavailability of iron in different weaning foods and the enhancing effect of a fruit drink containing ascorbic acid. Pediatr Res 1995; 37:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/58\">",
"      Abrams SA, O'Brien KO, Wen J, et al. Absorption by 1-year-old children of an iron supplement given with cow's milk or juice. Pediatr Res 1996; 39:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/59\">",
"      Hyams JS, Etienne NL, Leichtner AM, Theuer RC. Carbohydrate malabsorption following fruit juice ingestion in young children. Pediatrics 1988; 82:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/60\">",
"      Duro D, Rising R, Cedillo M, Lifshitz F. Association between infantile colic and carbohydrate malabsorption from fruit juices in infancy. Pediatrics 2002; 109:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/61\">",
"      Cole CR, Rising R, Lifshitz F. Consequences of incomplete carbohydrate absorption from fruit juice consumption in infants. Arch Pediatr Adolesc Med 1999; 153:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/62\">",
"      Smith MM, Davis M, Chasalow FI, Lifshitz F. Carbohydrate absorption from fruit juice in young children. Pediatrics 1995; 95:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/63\">",
"      Dennison BA. Fruit juice consumption by infants and children: a review. J Am Coll Nutr 1996; 15:4S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/64\">",
"      Lifschitz CH. Carbohydrate absorption from fruit juices in infants. Pediatrics 2000; 105:e4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/65\">",
"      Smith MM, Lifshitz F. Excess fruit juice consumption as a contributing factor in nonorganic failure to thrive. Pediatrics 1994; 93:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/66\">",
"      K&ouml;nig KG, Navia JM. Nutritional role of sugars in oral health. Am J Clin Nutr 1995; 62:275S.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Formula feeding of term infants. In: Pediatric Nutrition Handbook, 6, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village 2009. p.61.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/68\">",
"      Hopkins D, Emmett P, Steer C, et al. Infant feeding in the second 6 months of life related to iron status: an observational study. Arch Dis Child 2007; 92:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/69\">",
"      American Academy of Pediatrics Committee on Nutrition: The use of whole cow's milk in infancy. Pediatrics 1992; 89:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/70\">",
"      Arnon SS, Midura TF, Damus K, et al. Honey and other environmental risk factors for infant botulism. J Pediatr 1979; 94:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/71\">",
"      Fomon SJ. Feeding normal infants: rationale for recommendations. J Am Diet Assoc 2001; 101:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/72\">",
"      Hodges EA, Hughes SO, Hopkinson J, Fisher JO. Maternal decisions about the initiation and termination of infant feeding. Appetite 2008; 50:333.",
"     </a>",
"    </li>",
"    <li>",
"     Promoting healthy nutrition. In: right Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2008. p.121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/74\">",
"      Sullivan SA, Birch LL. Infant dietary experience and acceptance of solid foods. Pediatrics 1994; 93:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/75\">",
"      Forestell CA, Mennella JA. Early determinants of fruit and vegetable acceptance. Pediatrics 2007; 120:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/76\">",
"      Benton D. Role of parents in the determination of the food preferences of children and the development of obesity. Int J Obes Relat Metab Disord 2004; 28:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/77\">",
"      Hendricks K, Briefel R, Novak T, Ziegler P. Maternal and child characteristics associated with infant and toddler feeding practices. J Am Diet Assoc 2006; 106:S135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/78\">",
"      Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010; 126:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/79\">",
"      Calvo EB, Galindo AC, Aspres NB. Iron status in exclusively breast-fed infants. Pediatrics 1992; 90:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/80\">",
"      Walter T, Dallman PR, Pizarro F, et al. Effectiveness of iron-fortified infant cereal in prevention of iron deficiency anemia. Pediatrics 1993; 91:976.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition, American Academy of Pediatrics. Nutritional needs of the preterm infant. In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village 2009. p.79.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/43/10938/abstract/82\">",
"      Recommendations for using fluoride to prevent and control dental caries in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 2001; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition American Academy of Pediatrics. Vitamins. In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.453.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2855 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-B1BE4F5CD0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10938=[""].join("\n");
var outline_f10_43_10938=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INFANT NUTRITIONAL REQUIREMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HUMAN MILK AND INFANT FORMULA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      COMPLEMENTARY FOODS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      WHEN TO INITIATE COMPLEMENTARY FOODS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Optimal timing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Developmental skills",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Early introduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Lack of benefit",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Potential harms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Potential harms of delayed introduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      WHAT TO FEED AND HOW TO ADVANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      What to feed",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Cereals",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Pur&eacute;ed foods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Fruit juice",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Cow's milk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Foods to avoid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      How much to feed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      How to advance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Pur&eacute;es",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Finger foods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Self-feeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Feeding environment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      MINERAL AND VITAMIN SUPPLEMENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Iron",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Fluoride",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Vitamin B12",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Fat-soluble vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2855\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2855|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/15/40190\" title=\"figure 1\">",
"      Energy requirements of infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2855|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/6/3180\" title=\"table 1\">",
"      DRI infants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/37/30301\" title=\"table 2\">",
"      Infant feeding guide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/16/30987\" title=\"table 3\">",
"      Fluoride supplementation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42616?source=related_link\">",
"      Breastfeeding: Parental education and support",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/11/8378?source=related_link\">",
"      Clinical evaluation of the obese child and adolescent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=related_link\">",
"      Clinical manifestations and diagnosis of celiac disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=related_link\">",
"      Definition; epidemiology; and etiology of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=related_link\">",
"      Dietary recommendations for toddlers, preschool, and school-age children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16426?source=related_link\">",
"      Food poisoning in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=related_link\">",
"      Gastroesophageal reflux in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23657?source=related_link\">",
"      Gastroesophageal reflux in premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=related_link\">",
"      Genetics and pathogenesis of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=related_link\">",
"      Infant benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=related_link\">",
"      Introducing formula and solid foods to infants at risk for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=related_link\">",
"      Normal growth patterns in infants and prepubertal children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=related_link\">",
"      Nutritional composition of human milk for full-term infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33098?source=related_link\">",
"      Overview of acquired peripheral neuropathies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=related_link\">",
"      Pathogenesis of type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/32/41476?source=related_link\">",
"      Patient information: Starting solid foods during infancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/59/7091?source=related_link\">",
"      Patient information: Starting solid foods with babies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/0/25602?source=related_link\">",
"      Patient information: Weaning from breastfeeding (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/27/4531?source=related_link\">",
"      Patient information: Weaning from breastfeeding (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33192?source=related_link\">",
"      Preventive dental care and counseling for infants and young children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=related_link\">",
"      Vegetarian diets for children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=related_link\">",
"      Vitamin D insufficiency and deficiency in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_43_10939="History taking in ACD";
var content_f10_43_10939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F65321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F65321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    History taking in allergic contact dermatitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Demographics and occupational history",
"       </td>",
"       <td>",
"        Age, gender, race, ethnicity, religion, social aspects (marital status), job title, job description, regular and occasional chemical exposures and sources, location of employment, time at current job, previous occupations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family medical history",
"       </td>",
"       <td>",
"        Genetic factors, predispositions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Personal medical history",
"       </td>",
"       <td>",
"        Drug allergies, concomitant diseases, medications, surgeries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dermatitis-specific history",
"       </td>",
"       <td>",
"        Onset, location, temporal associations (waxings/wanings), treatments",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cohen DE, Jacob SE. Allergic contact dermatitis. In: Fitzpatrick's dermatology in general medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw-Hill Professional 2003. Copyright &copy; 2003 The McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10939=[""].join("\n");
var outline_f10_43_10939=null;
var title_f10_43_10940="Clin manif HIV P marneffei";
var content_f10_43_10940=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F68332&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F68332&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of HIV-infected patients with",
"    <em>",
"     Penicillium marneffei",
"    </em>",
"    infection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" rowspan=\"2\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"2\">",
"       Number of cases (percent)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       <p>",
"        Thailand",
"        <sup>",
"         [1]",
"        </sup>",
"       </p>",
"       <p>",
"        (N = 80)",
"       </p>",
"      </td>",
"      <td class=\"subtitle2\">",
"       <p>",
"        India",
"        <sup>",
"         [2]",
"        </sup>",
"       </p>",
"       <p>",
"        (N = 36)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fever",
"      </td>",
"      <td>",
"       79 (95)",
"      </td>",
"      <td>",
"       35 (97)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Weight loss",
"      </td>",
"      <td>",
"       61 (76)",
"      </td>",
"      <td>",
"       36 (100)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cough",
"      </td>",
"      <td>",
"       39 (49)",
"      </td>",
"      <td>",
"       N/A",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diarrhea",
"      </td>",
"      <td>",
"       25 (31)",
"      </td>",
"      <td>",
"       8 (22)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Skin lesions",
"      </td>",
"      <td>",
"       57 (71)",
"      </td>",
"      <td>",
"       29 (81)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Anemia",
"      </td>",
"      <td>",
"       62 (77)",
"      </td>",
"      <td>",
"       31 (86)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lymphadenopathy",
"      </td>",
"      <td>",
"       46 (57)",
"      </td>",
"      <td>",
"       12 (33)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hepatomegaly",
"      </td>",
"      <td>",
"       41 (51)",
"      </td>",
"      <td>",
"       14 (39)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Splenomegaly",
"      </td>",
"      <td>",
"       13 (16)",
"      </td>",
"      <td>",
"       14 (39)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Genital ulcer",
"      </td>",
"      <td>",
"       5 (6.2)",
"      </td>",
"      <td>",
"       N/A",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      1. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994; 344:110.",
"      <br>",
"       2. Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect Dis 2002; 45:268.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10940=[""].join("\n");
var outline_f10_43_10940=null;
var title_f10_43_10941="TNM group prostate CA";
var content_f10_43_10941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F67222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F67222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TNM anatomic stage prognostic groups for prostate cancer*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary tumor (T)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Regional lymph nodes (N)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Distant metastasis (M)",
"       </td>",
"       <td class=\"subtitle1\">",
"        PSA",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        I",
"       </td>",
"       <td>",
"        T1a-c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;10",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;10",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1-2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA X",
"       </td>",
"       <td>",
"        Gleason X",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        IIA",
"       </td>",
"       <td>",
"        T1a-c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;20",
"       </td>",
"       <td>",
"        Gleason 7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1a-c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &ge;10&lt;20",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &ge;10&lt;20",
"       </td>",
"       <td>",
"        Gleason &le;6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;20",
"       </td>",
"       <td>",
"        Gleason 7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &lt;20",
"       </td>",
"       <td>",
"        Gleason &le;7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T2b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA X",
"       </td>",
"       <td>",
"        Gleason X",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        IIB",
"       </td>",
"       <td>",
"        T2c",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1-2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        PSA &ge;20",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1-2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Gleason &ge;8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        T3a-b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        IV",
"       </td>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1",
"       </td>",
"       <td>",
"        Any PSA",
"       </td>",
"       <td>",
"        Any Gleason",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"     * When either PSA or Gleason is not available, grouping should be determined by T stage and/or either PSA or Gleason as available.",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10941=[""].join("\n");
var outline_f10_43_10941=null;
var title_f10_43_10942="Pulmonary osteoarthropathy II";
var content_f10_43_10942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70330&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70330&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary osteoarthropathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 163px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This plain film of the lower extremity in a woman who presented with ankle pain demonstrates marked periostitis with cortical and periosteal thickening, which has arisen in this patient with adenocarcinoma of the lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10942=[""].join("\n");
var outline_f10_43_10942=null;
var title_f10_43_10943="Avascular necrosis hip";
var content_f10_43_10943=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plain radiograph: Avascular necrosis of the hip (Legg-Calv&eacute;-Perthes disease)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 314px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Projection radiograph of the pelvis demonstrates characteristic changes of ischemic necrosis of the left femoral head (arrow). Mixed lucency and sclerosis along with coxa plana is typical of an active process.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the Department of Diagnostic Imaging, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_43_10943=[""].join("\n");
var outline_f10_43_10943=null;
